WO2018181707A1 - 歯科材料用接着性モノマー - Google Patents
歯科材料用接着性モノマー Download PDFInfo
- Publication number
- WO2018181707A1 WO2018181707A1 PCT/JP2018/013232 JP2018013232W WO2018181707A1 WO 2018181707 A1 WO2018181707 A1 WO 2018181707A1 JP 2018013232 W JP2018013232 W JP 2018013232W WO 2018181707 A1 WO2018181707 A1 WO 2018181707A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- general formula
- represented
- monomer
- dental
- Prior art date
Links
- 239000005548 dental material Substances 0.000 title claims abstract description 193
- 239000000178 monomer Substances 0.000 title claims abstract description 186
- 239000000853 adhesive Substances 0.000 title claims abstract description 114
- 230000001070 adhesive effect Effects 0.000 title claims abstract description 114
- 150000001875 compounds Chemical class 0.000 claims abstract description 58
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 claims abstract description 52
- 125000005647 linker group Chemical group 0.000 claims abstract description 52
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 31
- 229910052698 phosphorus Inorganic materials 0.000 claims abstract description 29
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000011574 phosphorus Substances 0.000 claims abstract description 28
- 125000000962 organic group Chemical group 0.000 claims abstract description 24
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 16
- 125000004430 oxygen atom Chemical group O* 0.000 claims abstract description 11
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract description 10
- 125000001183 hydrocarbyl group Chemical group 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims description 90
- 238000012360 testing method Methods 0.000 claims description 83
- -1 acryloyloxymethylene group Chemical group 0.000 claims description 66
- 125000004432 carbon atom Chemical group C* 0.000 claims description 66
- 125000002947 alkylene group Chemical group 0.000 claims description 16
- 125000005702 oxyalkylene group Chemical group 0.000 claims description 14
- 230000035772 mutation Effects 0.000 claims description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 125000004429 atom Chemical group 0.000 claims description 4
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 150000002430 hydrocarbons Chemical group 0.000 description 44
- 239000000243 solution Substances 0.000 description 42
- 210000004027 cell Anatomy 0.000 description 36
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 32
- 229910052760 oxygen Inorganic materials 0.000 description 32
- 239000001301 oxygen Substances 0.000 description 32
- 239000000126 substance Substances 0.000 description 30
- 238000004519 manufacturing process Methods 0.000 description 29
- 238000000034 method Methods 0.000 description 28
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 26
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 25
- 239000000047 product Substances 0.000 description 25
- 239000000463 material Substances 0.000 description 23
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 20
- 239000012085 test solution Substances 0.000 description 19
- 239000000945 filler Substances 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 15
- 125000006353 oxyethylene group Chemical group 0.000 description 15
- 239000002253 acid Substances 0.000 description 14
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 14
- 125000003277 amino group Chemical group 0.000 description 13
- 239000003505 polymerization initiator Substances 0.000 description 13
- 239000011347 resin Substances 0.000 description 13
- 229920005989 resin Polymers 0.000 description 13
- 125000000753 cycloalkyl group Chemical group 0.000 description 12
- 239000013642 negative control Substances 0.000 description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 11
- 238000002835 absorbance Methods 0.000 description 11
- 239000000805 composite resin Substances 0.000 description 11
- 229940125782 compound 2 Drugs 0.000 description 11
- 239000003479 dental cement Substances 0.000 description 11
- 229920001817 Agar Polymers 0.000 description 10
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- VFHVQBAGLAREND-UHFFFAOYSA-N diphenylphosphoryl-(2,4,6-trimethylphenyl)methanone Chemical compound CC1=CC(C)=CC(C)=C1C(=O)P(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 VFHVQBAGLAREND-UHFFFAOYSA-N 0.000 description 10
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 10
- CFKBCVIYTWDYRP-UHFFFAOYSA-N 10-phosphonooxydecyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCCCCCOP(O)(O)=O CFKBCVIYTWDYRP-UHFFFAOYSA-N 0.000 description 9
- HWSSEYVMGDIFMH-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOC(=O)C(C)=C HWSSEYVMGDIFMH-UHFFFAOYSA-N 0.000 description 9
- 239000003638 chemical reducing agent Substances 0.000 description 9
- 125000003700 epoxy group Chemical group 0.000 description 9
- 229920005862 polyol Polymers 0.000 description 9
- 238000005452 bending Methods 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 150000003077 polyols Chemical class 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 241000283690 Bos taurus Species 0.000 description 7
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 7
- 230000010261 cell growth Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 239000004215 Carbon black (E152) Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 6
- 239000004568 cement Substances 0.000 description 6
- 150000001805 chlorine compounds Chemical class 0.000 description 6
- 210000004268 dentin Anatomy 0.000 description 6
- 238000011049 filling Methods 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- 229930195733 hydrocarbon Natural products 0.000 description 6
- 239000003999 initiator Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 6
- 150000001451 organic peroxides Chemical class 0.000 description 6
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 5
- 230000004913 activation Effects 0.000 description 5
- 125000002015 acyclic group Chemical group 0.000 description 5
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 125000000732 arylene group Chemical group 0.000 description 5
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 5
- 239000007795 chemical reaction product Substances 0.000 description 5
- 125000002993 cycloalkylene group Chemical group 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- 239000011256 inorganic filler Substances 0.000 description 5
- 229910003475 inorganic filler Inorganic materials 0.000 description 5
- 230000002503 metabolic effect Effects 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 150000002978 peroxides Chemical class 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- KXDHJXZQYSOELW-UHFFFAOYSA-N Carbamic acid Chemical group NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- AMFGWXWBFGVCKG-UHFFFAOYSA-N Panavia opaque Chemical compound C1=CC(OCC(O)COC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OCC(O)COC(=O)C(C)=C)C=C1 AMFGWXWBFGVCKG-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 230000003833 cell viability Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 210000003298 dental enamel Anatomy 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 150000003512 tertiary amines Chemical class 0.000 description 4
- VNQXSTWCDUXYEZ-UHFFFAOYSA-N 1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione Chemical compound C1CC2(C)C(=O)C(=O)C1C2(C)C VNQXSTWCDUXYEZ-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- UEKHZPDUBLCUHN-UHFFFAOYSA-N 2-[[3,5,5-trimethyl-6-[2-(2-methylprop-2-enoyloxy)ethoxycarbonylamino]hexyl]carbamoyloxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOC(=O)NCCC(C)CC(C)(C)CNC(=O)OCCOC(=O)C(C)=C UEKHZPDUBLCUHN-UHFFFAOYSA-N 0.000 description 3
- JUVSRZCUMWZBFK-UHFFFAOYSA-N 2-[n-(2-hydroxyethyl)-4-methylanilino]ethanol Chemical compound CC1=CC=C(N(CCO)CCO)C=C1 JUVSRZCUMWZBFK-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 3
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical group OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- MCMNRKCIXSYSNV-UHFFFAOYSA-N ZrO2 Inorganic materials O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 3
- GWUIMLVRUIQFRX-UHFFFAOYSA-N [2,9-dicarbamoyloxy-5,7,7-trimethyl-10-(2-methylprop-2-enoyloxy)decyl] 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC(OC(N)=O)CCC(C)CC(C)(C)CC(COC(=O)C(C)=C)OC(N)=O GWUIMLVRUIQFRX-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000004840 adhesive resin Substances 0.000 description 3
- 229920006223 adhesive resin Polymers 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 229960003942 amphotericin b Drugs 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 229930006711 bornane-2,3-dione Natural products 0.000 description 3
- 239000005388 borosilicate glass Substances 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 3
- 229940125904 compound 1 Drugs 0.000 description 3
- 231100000263 cytotoxicity test Toxicity 0.000 description 3
- 239000011350 dental composite resin Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical group OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 3
- 238000007599 discharging Methods 0.000 description 3
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000012948 isocyanate Substances 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 229910000077 silane Inorganic materials 0.000 description 3
- 125000000542 sulfonic acid group Chemical group 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- HHQAGBQXOWLTLL-UHFFFAOYSA-N (2-hydroxy-3-phenoxypropyl) prop-2-enoate Chemical compound C=CC(=O)OCC(O)COC1=CC=CC=C1 HHQAGBQXOWLTLL-UHFFFAOYSA-N 0.000 description 2
- ALVZNPYWJMLXKV-UHFFFAOYSA-N 1,9-Nonanediol Chemical compound OCCCCCCCCCO ALVZNPYWJMLXKV-UHFFFAOYSA-N 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 2
- YMHOBZXQZVXHBM-UHFFFAOYSA-N 2,5-dimethoxy-4-bromophenethylamine Chemical compound COC1=CC(CCN)=C(OC)C=C1Br YMHOBZXQZVXHBM-UHFFFAOYSA-N 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- LEJBBGNFPAFPKQ-UHFFFAOYSA-N 2-(2-prop-2-enoyloxyethoxy)ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOC(=O)C=C LEJBBGNFPAFPKQ-UHFFFAOYSA-N 0.000 description 2
- JDKSTARXLKKYPS-UHFFFAOYSA-N 2-[10-(2-methylprop-2-enoyloxy)decyl]propanedioic acid Chemical compound CC(=C)C(=O)OCCCCCCCCCCC(C(O)=O)C(O)=O JDKSTARXLKKYPS-UHFFFAOYSA-N 0.000 description 2
- XFCMNSHQOZQILR-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOC(=O)C(C)=C XFCMNSHQOZQILR-UHFFFAOYSA-N 0.000 description 2
- INQDDHNZXOAFFD-UHFFFAOYSA-N 2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOCCOC(=O)C=C INQDDHNZXOAFFD-UHFFFAOYSA-N 0.000 description 2
- HCLJOFJIQIJXHS-UHFFFAOYSA-N 2-[2-[2-(2-prop-2-enoyloxyethoxy)ethoxy]ethoxy]ethyl prop-2-enoate Chemical compound C=CC(=O)OCCOCCOCCOCCOC(=O)C=C HCLJOFJIQIJXHS-UHFFFAOYSA-N 0.000 description 2
- PAAVDLDRAZEFGW-UHFFFAOYSA-N 2-butoxyethyl 4-(dimethylamino)benzoate Chemical compound CCCCOCCOC(=O)C1=CC=C(N(C)C)C=C1 PAAVDLDRAZEFGW-UHFFFAOYSA-N 0.000 description 2
- NJRHMGPRPPEGQL-UHFFFAOYSA-N 2-hydroxybutyl prop-2-enoate Chemical compound CCC(O)COC(=O)C=C NJRHMGPRPPEGQL-UHFFFAOYSA-N 0.000 description 2
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 2
- GWZMWHWAWHPNHN-UHFFFAOYSA-N 2-hydroxypropyl prop-2-enoate Chemical compound CC(O)COC(=O)C=C GWZMWHWAWHPNHN-UHFFFAOYSA-N 0.000 description 2
- KUDUQBURMYMBIJ-UHFFFAOYSA-N 2-prop-2-enoyloxyethyl prop-2-enoate Chemical compound C=CC(=O)OCCOC(=O)C=C KUDUQBURMYMBIJ-UHFFFAOYSA-N 0.000 description 2
- FRIBMENBGGCKPD-UHFFFAOYSA-N 3-(2,3-dimethoxyphenyl)prop-2-enal Chemical compound COC1=CC=CC(C=CC=O)=C1OC FRIBMENBGGCKPD-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- 238000010953 Ames test Methods 0.000 description 2
- 231100000039 Ames test Toxicity 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- 238000009631 Broth culture Methods 0.000 description 2
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 208000006077 Dental Fissures Diseases 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- 239000006087 Silane Coupling Agent Substances 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000545067 Venus Species 0.000 description 2
- URLYGBGJPQYXBN-UHFFFAOYSA-N [4-(hydroxymethyl)cyclohexyl]methyl prop-2-enoate Chemical compound OCC1CCC(COC(=O)C=C)CC1 URLYGBGJPQYXBN-UHFFFAOYSA-N 0.000 description 2
- UKLDJPRMSDWDSL-UHFFFAOYSA-L [dibutyl(dodecanoyloxy)stannyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)O[Sn](CCCC)(CCCC)OC(=O)CCCCCCCCCCC UKLDJPRMSDWDSL-UHFFFAOYSA-L 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 229910052788 barium Inorganic materials 0.000 description 2
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- NEHNMFOYXAPHSD-UHFFFAOYSA-N citronellal Chemical compound O=CCC(C)CCC=C(C)C NEHNMFOYXAPHSD-UHFFFAOYSA-N 0.000 description 2
- 229940126214 compound 3 Drugs 0.000 description 2
- 229940125898 compound 5 Drugs 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical group CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 2
- 125000004386 diacrylate group Chemical group 0.000 description 2
- 239000012933 diacyl peroxide Substances 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 239000012975 dibutyltin dilaurate Substances 0.000 description 2
- 125000005442 diisocyanate group Chemical group 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- UHESRSKEBRADOO-UHFFFAOYSA-N ethyl carbamate;prop-2-enoic acid Chemical compound OC(=O)C=C.CCOC(N)=O UHESRSKEBRADOO-UHFFFAOYSA-N 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 239000003955 fissure sealant Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- RBQRWNWVPQDTJJ-UHFFFAOYSA-N methacryloyloxyethyl isocyanate Chemical compound CC(=C)C(=O)OCCN=C=O RBQRWNWVPQDTJJ-UHFFFAOYSA-N 0.000 description 2
- CRVGTESFCCXCTH-UHFFFAOYSA-N methyl diethanolamine Chemical compound OCCN(C)CCO CRVGTESFCCXCTH-UHFFFAOYSA-N 0.000 description 2
- 239000012766 organic filler Substances 0.000 description 2
- FZUGPQWGEGAKET-UHFFFAOYSA-N parbenate Chemical compound CCOC(=O)C1=CC=C(N(C)C)C=C1 FZUGPQWGEGAKET-UHFFFAOYSA-N 0.000 description 2
- TZMFJUDUGYTVRY-UHFFFAOYSA-N pentane-2,3-dione Chemical compound CCC(=O)C(C)=O TZMFJUDUGYTVRY-UHFFFAOYSA-N 0.000 description 2
- 125000002270 phosphoric acid ester group Chemical group 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 238000000016 photochemical curing Methods 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001483 poly(ethyl methacrylate) polymer Polymers 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 238000007717 redox polymerization reaction Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229940054269 sodium pyruvate Drugs 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- BUUPQKDIAURBJP-UHFFFAOYSA-N sulfinic acid Chemical compound OS=O BUUPQKDIAURBJP-UHFFFAOYSA-N 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 239000012756 surface treatment agent Substances 0.000 description 2
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- YRHRIQCWCFGUEQ-UHFFFAOYSA-N thioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3SC2=C1 YRHRIQCWCFGUEQ-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 2
- HGTUJZTUQFXBIH-UHFFFAOYSA-N (2,3-dimethyl-3-phenylbutan-2-yl)benzene Chemical group C=1C=CC=CC=1C(C)(C)C(C)(C)C1=CC=CC=C1 HGTUJZTUQFXBIH-UHFFFAOYSA-N 0.000 description 1
- WRXCBRHBHGNNQA-UHFFFAOYSA-N (2,4-dichlorobenzoyl) 2,4-dichlorobenzenecarboperoxoate Chemical compound ClC1=CC(Cl)=CC=C1C(=O)OOC(=O)C1=CC=C(Cl)C=C1Cl WRXCBRHBHGNNQA-UHFFFAOYSA-N 0.000 description 1
- SUEDCWGEKSLKOM-UHFFFAOYSA-N (2,6-dimethoxyphenyl)-diphenylphosphorylmethanone Chemical compound COC1=CC=CC(OC)=C1C(=O)P(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 SUEDCWGEKSLKOM-UHFFFAOYSA-N 0.000 description 1
- FVQMJJQUGGVLEP-UHFFFAOYSA-N (2-methylpropan-2-yl)oxy 2-ethylhexaneperoxoate Chemical compound CCCCC(CC)C(=O)OOOC(C)(C)C FVQMJJQUGGVLEP-UHFFFAOYSA-N 0.000 description 1
- QEQBMZQFDDDTPN-UHFFFAOYSA-N (2-methylpropan-2-yl)oxy benzenecarboperoxoate Chemical compound CC(C)(C)OOOC(=O)C1=CC=CC=C1 QEQBMZQFDDDTPN-UHFFFAOYSA-N 0.000 description 1
- KDGNCLDCOVTOCS-UHFFFAOYSA-N (2-methylpropan-2-yl)oxy propan-2-yl carbonate Chemical compound CC(C)OC(=O)OOC(C)(C)C KDGNCLDCOVTOCS-UHFFFAOYSA-N 0.000 description 1
- NLBJAOHLJABDAU-UHFFFAOYSA-N (3-methylbenzoyl) 3-methylbenzenecarboperoxoate Chemical compound CC1=CC=CC(C(=O)OOC(=O)C=2C=C(C)C=CC=2)=C1 NLBJAOHLJABDAU-UHFFFAOYSA-N 0.000 description 1
- RIPYNJLMMFGZSX-UHFFFAOYSA-N (5-benzoylperoxy-2,5-dimethylhexan-2-yl) benzenecarboperoxoate Chemical compound C=1C=CC=CC=1C(=O)OOC(C)(C)CCC(C)(C)OOC(=O)C1=CC=CC=C1 RIPYNJLMMFGZSX-UHFFFAOYSA-N 0.000 description 1
- NALFRYPTRXKZPN-UHFFFAOYSA-N 1,1-bis(tert-butylperoxy)-3,3,5-trimethylcyclohexane Chemical compound CC1CC(C)(C)CC(OOC(C)(C)C)(OOC(C)(C)C)C1 NALFRYPTRXKZPN-UHFFFAOYSA-N 0.000 description 1
- 229940008841 1,6-hexamethylene diisocyanate Drugs 0.000 description 1
- ZDQNWDNMNKSMHI-UHFFFAOYSA-N 1-[2-(2-prop-2-enoyloxypropoxy)propoxy]propan-2-yl prop-2-enoate Chemical compound C=CC(=O)OC(C)COC(C)COCC(C)OC(=O)C=C ZDQNWDNMNKSMHI-UHFFFAOYSA-N 0.000 description 1
- AOCWFZYXOMHKQJ-UHFFFAOYSA-N 1-ethoxy-2-(2-hydroxyethoxy)ethanol;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CCOC(O)COCCO AOCWFZYXOMHKQJ-UHFFFAOYSA-N 0.000 description 1
- OBNIRVVPHSLTEP-UHFFFAOYSA-N 1-ethoxy-2-(2-hydroxyethoxy)ethanol;prop-2-enoic acid Chemical compound OC(=O)C=C.CCOC(O)COCCO OBNIRVVPHSLTEP-UHFFFAOYSA-N 0.000 description 1
- LRZPQLZONWIQOJ-UHFFFAOYSA-N 10-(2-methylprop-2-enoyloxy)decyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCCCCCOC(=O)C(C)=C LRZPQLZONWIQOJ-UHFFFAOYSA-N 0.000 description 1
- PREIHGSIAPRHNC-UHFFFAOYSA-N 10-dihydroxyphosphinothioyloxydecyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCCCCCOP(O)(O)=S PREIHGSIAPRHNC-UHFFFAOYSA-N 0.000 description 1
- LPLFTYJAPSRTEJ-UHFFFAOYSA-N 10-dihydroxyphosphinothioyloxydecyl prop-2-enoate Chemical compound P(=S)(OCCCCCCCCCCOC(C=C)=O)(O)O LPLFTYJAPSRTEJ-UHFFFAOYSA-N 0.000 description 1
- NTMDDSQESSRCTM-UHFFFAOYSA-N 10-phosphonooxydecyl prop-2-enoate Chemical compound OP(O)(=O)OCCCCCCCCCCOC(=O)C=C NTMDDSQESSRCTM-UHFFFAOYSA-N 0.000 description 1
- RHNJVKIVSXGYBD-UHFFFAOYSA-N 10-prop-2-enoyloxydecyl prop-2-enoate Chemical compound C=CC(=O)OCCCCCCCCCCOC(=O)C=C RHNJVKIVSXGYBD-UHFFFAOYSA-N 0.000 description 1
- XWHWRFLIGWRUDE-UHFFFAOYSA-N 11-phosphonooxyundecyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCCCCCCOP(O)(O)=O XWHWRFLIGWRUDE-UHFFFAOYSA-N 0.000 description 1
- MZUJONYVTUNSPW-UHFFFAOYSA-N 11-phosphonooxyundecyl prop-2-enoate Chemical compound OP(O)(=O)OCCCCCCCCCCCOC(=O)C=C MZUJONYVTUNSPW-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- BTJPUDCSZVCXFQ-UHFFFAOYSA-N 2,4-diethylthioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC(CC)=CC(CC)=C3SC2=C1 BTJPUDCSZVCXFQ-UHFFFAOYSA-N 0.000 description 1
- GOCCZHBIWRMQAU-UHFFFAOYSA-N 2-(10-prop-2-enoyloxydecyl)propanedioic acid Chemical compound OC(=O)C(C(O)=O)CCCCCCCCCCOC(=O)C=C GOCCZHBIWRMQAU-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- PRAMZQXXPOLCIY-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethanesulfonic acid Chemical compound CC(=C)C(=O)OCCS(O)(=O)=O PRAMZQXXPOLCIY-UHFFFAOYSA-N 0.000 description 1
- LELXPLKBYMRGAQ-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethoxy-phenylphosphinic acid Chemical compound CC(=C)C(=O)OCCOP(O)(=O)C1=CC=CC=C1 LELXPLKBYMRGAQ-UHFFFAOYSA-N 0.000 description 1
- JJBFVQSGPLGDNX-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)propyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C)COC(=O)C(C)=C JJBFVQSGPLGDNX-UHFFFAOYSA-N 0.000 description 1
- CHLIEYMSXLYEBR-UHFFFAOYSA-N 2-(2-phosphonooxyphenyl)ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC1=CC=CC=C1OP(O)(O)=O CHLIEYMSXLYEBR-UHFFFAOYSA-N 0.000 description 1
- FHCBFWPNQZFQAI-UHFFFAOYSA-N 2-(2-phosphonooxyphenyl)ethyl prop-2-enoate Chemical compound P(=O)(OC1=C(C=CC=C1)CCOC(C=C)=O)(O)O FHCBFWPNQZFQAI-UHFFFAOYSA-N 0.000 description 1
- DGPBVJWCIDNDPN-UHFFFAOYSA-N 2-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=CC=C1C=O DGPBVJWCIDNDPN-UHFFFAOYSA-N 0.000 description 1
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- JQCWCBBBJXQKDE-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]-1-methoxyethanol;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.COC(O)COCCOCCO JQCWCBBBJXQKDE-UHFFFAOYSA-N 0.000 description 1
- COORVRSSRBIIFJ-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]-1-methoxyethanol;prop-2-enoic acid Chemical compound OC(=O)C=C.COC(O)COCCOCCO COORVRSSRBIIFJ-UHFFFAOYSA-N 0.000 description 1
- YCFHWQVZPBKIFW-UHFFFAOYSA-N 2-[2-(2-methylprop-2-enoyloxy)ethoxy-phosphonooxyphosphoryl]oxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOP(=O)(OP(O)(O)=O)OCCOC(=O)C(C)=C YCFHWQVZPBKIFW-UHFFFAOYSA-N 0.000 description 1
- OWDBMKZHFCSOOL-UHFFFAOYSA-N 2-[2-[2-(2-methylprop-2-enoyloxy)propoxy]propoxy]propyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC(C)COC(C)COC(C)COC(=O)C(C)=C OWDBMKZHFCSOOL-UHFFFAOYSA-N 0.000 description 1
- LTHJXDSHSVNJKG-UHFFFAOYSA-N 2-[2-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOCCOCCOCCOC(=O)C(C)=C LTHJXDSHSVNJKG-UHFFFAOYSA-N 0.000 description 1
- HLDMOJRATBJDBV-UHFFFAOYSA-N 2-[3,5-ditert-butyl-n-(2-hydroxyethyl)anilino]ethanol Chemical compound CC(C)(C)C1=CC(N(CCO)CCO)=CC(C(C)(C)C)=C1 HLDMOJRATBJDBV-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- IFMADWRJVDIYMF-UHFFFAOYSA-N 2-[4-ethyl-n-(2-hydroxyethyl)anilino]ethanol Chemical compound CCC1=CC=C(N(CCO)CCO)C=C1 IFMADWRJVDIYMF-UHFFFAOYSA-N 0.000 description 1
- IEXYKOLCMBHVMG-UHFFFAOYSA-N 2-[4-tert-butyl-n-(2-hydroxyethyl)anilino]ethanol Chemical compound CC(C)(C)C1=CC=C(N(CCO)CCO)C=C1 IEXYKOLCMBHVMG-UHFFFAOYSA-N 0.000 description 1
- KTCJIXFHCDQCLI-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCN(CCO)CCO KTCJIXFHCDQCLI-UHFFFAOYSA-N 0.000 description 1
- NKFNBVMJTSYZDV-UHFFFAOYSA-N 2-[dodecyl(2-hydroxyethyl)amino]ethanol Chemical compound CCCCCCCCCCCCN(CCO)CCO NKFNBVMJTSYZDV-UHFFFAOYSA-N 0.000 description 1
- BHICZSRCJVGOGG-UHFFFAOYSA-N 2-[ethyl-[2-(2-methylprop-2-enoyloxy)ethyl]amino]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCN(CC)CCOC(=O)C(C)=C BHICZSRCJVGOGG-UHFFFAOYSA-N 0.000 description 1
- DMTMWMUHQLDCKP-UHFFFAOYSA-N 2-[n-(2-hydroxyethyl)-3,4-dimethylanilino]ethanol Chemical compound CC1=CC=C(N(CCO)CCO)C=C1C DMTMWMUHQLDCKP-UHFFFAOYSA-N 0.000 description 1
- JWQRYFYKHVZIDQ-UHFFFAOYSA-N 2-[n-(2-hydroxyethyl)-3,5-dimethylanilino]ethanol Chemical compound CC1=CC(C)=CC(N(CCO)CCO)=C1 JWQRYFYKHVZIDQ-UHFFFAOYSA-N 0.000 description 1
- MRRQHESYIOYHKD-UHFFFAOYSA-N 2-[n-(2-hydroxyethyl)-3,5-dipropylanilino]ethanol Chemical compound CCCC1=CC(CCC)=CC(N(CCO)CCO)=C1 MRRQHESYIOYHKD-UHFFFAOYSA-N 0.000 description 1
- OBZIDOKKXAWNDR-UHFFFAOYSA-N 2-[n-(2-hydroxyethyl)-4-propylanilino]ethanol Chemical compound CCCC1=CC=C(N(CCO)CCO)C=C1 OBZIDOKKXAWNDR-UHFFFAOYSA-N 0.000 description 1
- YRKHGZPCDIKARV-UHFFFAOYSA-N 2-[phosphonooxy(2-prop-2-enoyloxyethoxy)phosphoryl]oxyethyl prop-2-enoate Chemical compound OP(O)(=O)OP(=O)(OCCOC(=O)C=C)OCCOC(=O)C=C YRKHGZPCDIKARV-UHFFFAOYSA-N 0.000 description 1
- ZCDADJXRUCOCJE-UHFFFAOYSA-N 2-chlorothioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC(Cl)=CC=C3SC2=C1 ZCDADJXRUCOCJE-UHFFFAOYSA-N 0.000 description 1
- AJLILEBCCVYDKP-UHFFFAOYSA-N 2-dihydroxyphosphinothioylsulfanylethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCSP(O)(O)=S AJLILEBCCVYDKP-UHFFFAOYSA-N 0.000 description 1
- FBMFNPYKILVLNP-UHFFFAOYSA-N 2-dihydroxyphosphinothioylsulfanylethyl prop-2-enoate Chemical compound P(=S)(SCCOC(C=C)=O)(O)O FBMFNPYKILVLNP-UHFFFAOYSA-N 0.000 description 1
- IEVADDDOVGMCSI-UHFFFAOYSA-N 2-hydroxybutyl 2-methylprop-2-enoate Chemical compound CCC(O)COC(=O)C(C)=C IEVADDDOVGMCSI-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- VHSHLMUCYSAUQU-UHFFFAOYSA-N 2-hydroxypropyl methacrylate Chemical compound CC(O)COC(=O)C(C)=C VHSHLMUCYSAUQU-UHFFFAOYSA-N 0.000 description 1
- FLFWJIBUZQARMD-UHFFFAOYSA-N 2-mercapto-1,3-benzoxazole Chemical compound C1=CC=C2OC(S)=NC2=C1 FLFWJIBUZQARMD-UHFFFAOYSA-N 0.000 description 1
- SEILKFZTLVMHRR-UHFFFAOYSA-N 2-phosphonooxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOP(O)(O)=O SEILKFZTLVMHRR-UHFFFAOYSA-N 0.000 description 1
- UDXXYUDJOHIIDZ-UHFFFAOYSA-N 2-phosphonooxyethyl prop-2-enoate Chemical compound OP(O)(=O)OCCOC(=O)C=C UDXXYUDJOHIIDZ-UHFFFAOYSA-N 0.000 description 1
- GQTFHSAAODFMHB-UHFFFAOYSA-N 2-prop-2-enoyloxyethanesulfonic acid Chemical compound OS(=O)(=O)CCOC(=O)C=C GQTFHSAAODFMHB-UHFFFAOYSA-N 0.000 description 1
- VFZKVQVQOMDJEG-UHFFFAOYSA-N 2-prop-2-enoyloxypropyl prop-2-enoate Chemical compound C=CC(=O)OC(C)COC(=O)C=C VFZKVQVQOMDJEG-UHFFFAOYSA-N 0.000 description 1
- SMRMWHOIHCAQMQ-UHFFFAOYSA-N 20-phosphonooxyicosyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCCCCCCCCCCCCCCCOP(O)(O)=O SMRMWHOIHCAQMQ-UHFFFAOYSA-N 0.000 description 1
- VCGYBVUSUBUHLE-UHFFFAOYSA-N 20-phosphonooxyicosyl prop-2-enoate Chemical compound OP(O)(=O)OCCCCCCCCCCCCCCCCCCCCOC(=O)C=C VCGYBVUSUBUHLE-UHFFFAOYSA-N 0.000 description 1
- FIJRQSPKMCQFJU-UHFFFAOYSA-N 3,5-ditert-butyl-n,n-dimethylaniline Chemical compound CN(C)C1=CC(C(C)(C)C)=CC(C(C)(C)C)=C1 FIJRQSPKMCQFJU-UHFFFAOYSA-N 0.000 description 1
- UUEWCQRISZBELL-UHFFFAOYSA-N 3-trimethoxysilylpropane-1-thiol Chemical compound CO[Si](OC)(OC)CCCS UUEWCQRISZBELL-UHFFFAOYSA-N 0.000 description 1
- XOJWAAUYNWGQAU-UHFFFAOYSA-N 4-(2-methylprop-2-enoyloxy)butyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCOC(=O)C(C)=C XOJWAAUYNWGQAU-UHFFFAOYSA-N 0.000 description 1
- DOGUBQQBFMXVII-UHFFFAOYSA-N 4-(2-prop-2-enoyloxyethoxycarbonyl)phthalic acid Chemical compound OC(=O)C1=CC=C(C(=O)OCCOC(=O)C=C)C=C1C(O)=O DOGUBQQBFMXVII-UHFFFAOYSA-N 0.000 description 1
- YDIYEOMDOWUDTJ-UHFFFAOYSA-N 4-(dimethylamino)benzoic acid Chemical compound CN(C)C1=CC=C(C(O)=O)C=C1 YDIYEOMDOWUDTJ-UHFFFAOYSA-N 0.000 description 1
- GOGCLLMDQOJKHB-UHFFFAOYSA-N 4-[2-(2-methylprop-2-enoyloxy)ethoxycarbonyl]phthalic acid Chemical compound CC(=C)C(=O)OCCOC(=O)C1=CC=C(C(O)=O)C(C(O)=O)=C1 GOGCLLMDQOJKHB-UHFFFAOYSA-N 0.000 description 1
- VNGLVZLEUDIDQH-UHFFFAOYSA-N 4-[2-(4-hydroxyphenyl)propan-2-yl]phenol;2-methyloxirane Chemical compound CC1CO1.C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 VNGLVZLEUDIDQH-UHFFFAOYSA-N 0.000 description 1
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 1
- KLQNCSLBKKYPET-UHFFFAOYSA-N 4-ethyl-n,n-dimethylaniline Chemical compound CCC1=CC=C(N(C)C)C=C1 KLQNCSLBKKYPET-UHFFFAOYSA-N 0.000 description 1
- YKXAYLPDMSGWEV-UHFFFAOYSA-N 4-hydroxybutyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCO YKXAYLPDMSGWEV-UHFFFAOYSA-N 0.000 description 1
- NDWUBGAGUCISDV-UHFFFAOYSA-N 4-hydroxybutyl prop-2-enoate Chemical compound OCCCCOC(=O)C=C NDWUBGAGUCISDV-UHFFFAOYSA-N 0.000 description 1
- JHWGFJBTMHEZME-UHFFFAOYSA-N 4-prop-2-enoyloxybutyl prop-2-enoate Chemical compound C=CC(=O)OCCCCOC(=O)C=C JHWGFJBTMHEZME-UHFFFAOYSA-N 0.000 description 1
- SJDILFZCXQHCRB-UHFFFAOYSA-N 4-tert-butyl-n,n-dimethylaniline Chemical compound CN(C)C1=CC=C(C(C)(C)C)C=C1 SJDILFZCXQHCRB-UHFFFAOYSA-N 0.000 description 1
- WIYVVIUBKNTNKG-UHFFFAOYSA-N 6,7-dimethoxy-3,4-dihydronaphthalene-2-carboxylic acid Chemical compound C1CC(C(O)=O)=CC2=C1C=C(OC)C(OC)=C2 WIYVVIUBKNTNKG-UHFFFAOYSA-N 0.000 description 1
- FSFFIYOYBDBDMQ-UHFFFAOYSA-N 6-(2-methylprop-2-enoylamino)hexanoic acid Chemical compound CC(=C)C(=O)NCCCCCC(O)=O FSFFIYOYBDBDMQ-UHFFFAOYSA-N 0.000 description 1
- SAPGBCWOQLHKKZ-UHFFFAOYSA-N 6-(2-methylprop-2-enoyloxy)hexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCOC(=O)C(C)=C SAPGBCWOQLHKKZ-UHFFFAOYSA-N 0.000 description 1
- SAQWCPXBLNGTCC-UHFFFAOYSA-N 6-(prop-2-enoylamino)hexanoic acid Chemical compound OC(=O)CCCCCNC(=O)C=C SAQWCPXBLNGTCC-UHFFFAOYSA-N 0.000 description 1
- FIHBHSQYSYVZQE-UHFFFAOYSA-N 6-prop-2-enoyloxyhexyl prop-2-enoate Chemical compound C=CC(=O)OCCCCCCOC(=O)C=C FIHBHSQYSYVZQE-UHFFFAOYSA-N 0.000 description 1
- UBRPGRAGAZVZKQ-UHFFFAOYSA-N 8-(2-methylprop-2-enoyloxy)octyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCCCOC(=O)C(C)=C UBRPGRAGAZVZKQ-UHFFFAOYSA-N 0.000 description 1
- IHNQLRURNALWRJ-UHFFFAOYSA-N 8-prop-2-enoyloxyoctyl prop-2-enoate Chemical compound C=CC(=O)OCCCCCCCCOC(=O)C=C IHNQLRURNALWRJ-UHFFFAOYSA-N 0.000 description 1
- QXKNGUVSSZNTKF-UHFFFAOYSA-N 9-phosphonooxynonyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCCCCCCCOP(O)(O)=O QXKNGUVSSZNTKF-UHFFFAOYSA-N 0.000 description 1
- OUSRYBRPEYVGHG-UHFFFAOYSA-N 9-phosphonooxynonyl prop-2-enoate Chemical compound OP(O)(=O)OCCCCCCCCCOC(=O)C=C OUSRYBRPEYVGHG-UHFFFAOYSA-N 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N Bisphenol A Natural products C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- HQLJWZGLXGUBLN-UHFFFAOYSA-N CC(CP(=O)C(=O)c1c(C)ccc(C)c1C)CC(C)(C)C Chemical compound CC(CP(=O)C(=O)c1c(C)ccc(C)c1C)CC(C)(C)C HQLJWZGLXGUBLN-UHFFFAOYSA-N 0.000 description 1
- OTFAQGCBYAXPCR-UHFFFAOYSA-N CC1=C(C(=O)COP(C2=CC=CC=C2)=O)C(=CC(=C1)C)C Chemical compound CC1=C(C(=O)COP(C2=CC=CC=C2)=O)C(=CC(=C1)C)C OTFAQGCBYAXPCR-UHFFFAOYSA-N 0.000 description 1
- 102100026735 Coagulation factor VIII Human genes 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical class ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- YIVJZNGAASQVEM-UHFFFAOYSA-N Lauroyl peroxide Chemical compound CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC YIVJZNGAASQVEM-UHFFFAOYSA-N 0.000 description 1
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- AKNUHUCEWALCOI-UHFFFAOYSA-N N-ethyldiethanolamine Chemical compound OCCN(CC)CCO AKNUHUCEWALCOI-UHFFFAOYSA-N 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 101710151387 Serine protease 1 Proteins 0.000 description 1
- 102100032491 Serine protease 1 Human genes 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 101710119665 Trypsin-1 Proteins 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- IAXXETNIOYFMLW-GYSYKLTISA-N [(1r,3r,4r)-4,7,7-trimethyl-3-bicyclo[2.2.1]heptanyl] 2-methylprop-2-enoate Chemical compound C1C[C@@]2(C)[C@H](OC(=O)C(=C)C)C[C@@H]1C2(C)C IAXXETNIOYFMLW-GYSYKLTISA-N 0.000 description 1
- PRRGXULZOZTZDK-UHFFFAOYSA-N [(2,6-dichlorobenzoyl)-(2,5-dimethylphenyl)phosphoryl]-(2,6-dichlorophenyl)methanone Chemical compound CC1=CC=C(C)C(P(=O)(C(=O)C=2C(=CC=CC=2Cl)Cl)C(=O)C=2C(=CC=CC=2Cl)Cl)=C1 PRRGXULZOZTZDK-UHFFFAOYSA-N 0.000 description 1
- ZEDSKTISNTXEQI-UHFFFAOYSA-N [(2,6-dichlorobenzoyl)-(4-propylphenyl)phosphoryl]-(2,6-dichlorophenyl)methanone Chemical compound C1=CC(CCC)=CC=C1P(=O)(C(=O)C=1C(=CC=CC=1Cl)Cl)C(=O)C1=C(Cl)C=CC=C1Cl ZEDSKTISNTXEQI-UHFFFAOYSA-N 0.000 description 1
- YNJCLWHSZGZEAS-UHFFFAOYSA-N [(2,6-dichlorobenzoyl)-naphthalen-1-ylphosphoryl]-(2,6-dichlorophenyl)methanone Chemical compound ClC1=CC=CC(Cl)=C1C(=O)P(=O)(C=1C2=CC=CC=C2C=CC=1)C(=O)C1=C(Cl)C=CC=C1Cl YNJCLWHSZGZEAS-UHFFFAOYSA-N 0.000 description 1
- DNRISHWSPBDRTH-UHFFFAOYSA-N [(2,6-dichlorobenzoyl)-phenylphosphoryl]-(2,6-dichlorophenyl)methanone Chemical compound ClC1=CC=CC(Cl)=C1C(=O)P(=O)(C=1C=CC=CC=1)C(=O)C1=C(Cl)C=CC=C1Cl DNRISHWSPBDRTH-UHFFFAOYSA-N 0.000 description 1
- LFOXEOLGJPJZAA-UHFFFAOYSA-N [(2,6-dimethoxybenzoyl)-(2,4,4-trimethylpentyl)phosphoryl]-(2,6-dimethoxyphenyl)methanone Chemical compound COC1=CC=CC(OC)=C1C(=O)P(=O)(CC(C)CC(C)(C)C)C(=O)C1=C(OC)C=CC=C1OC LFOXEOLGJPJZAA-UHFFFAOYSA-N 0.000 description 1
- ZTCAGYRXUCWHPV-UHFFFAOYSA-N [(2,6-dimethoxybenzoyl)-(2,5-dimethylphenyl)phosphoryl]-(2,6-dimethoxyphenyl)methanone Chemical compound COC1=CC=CC(OC)=C1C(=O)P(=O)(C=1C(=CC=C(C)C=1)C)C(=O)C1=C(OC)C=CC=C1OC ZTCAGYRXUCWHPV-UHFFFAOYSA-N 0.000 description 1
- QISAYNXDUCNISJ-UHFFFAOYSA-N [(2,6-dimethoxybenzoyl)-phenylphosphoryl]-(2,6-dimethoxyphenyl)methanone Chemical compound COC1=CC=CC(OC)=C1C(=O)P(=O)(C=1C=CC=CC=1)C(=O)C1=C(OC)C=CC=C1OC QISAYNXDUCNISJ-UHFFFAOYSA-N 0.000 description 1
- VZTQQYMRXDUHDO-UHFFFAOYSA-N [2-hydroxy-3-[4-[2-[4-(2-hydroxy-3-prop-2-enoyloxypropoxy)phenyl]propan-2-yl]phenoxy]propyl] prop-2-enoate Chemical compound C=1C=C(OCC(O)COC(=O)C=C)C=CC=1C(C)(C)C1=CC=C(OCC(O)COC(=O)C=C)C=C1 VZTQQYMRXDUHDO-UHFFFAOYSA-N 0.000 description 1
- BEUGBYXJXMVRFO-UHFFFAOYSA-N [4-(dimethylamino)phenyl]-phenylmethanone Chemical compound C1=CC(N(C)C)=CC=C1C(=O)C1=CC=CC=C1 BEUGBYXJXMVRFO-UHFFFAOYSA-N 0.000 description 1
- KAOQCJIKVJCWDU-UHFFFAOYSA-N [4-(hydroxymethyl)cyclohexyl]methyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC1CCC(CO)CC1 KAOQCJIKVJCWDU-UHFFFAOYSA-N 0.000 description 1
- COHCXWLRUISKOO-UHFFFAOYSA-N [AlH3].[Ba] Chemical compound [AlH3].[Ba] COHCXWLRUISKOO-UHFFFAOYSA-N 0.000 description 1
- NOZAQBYNLKNDRT-UHFFFAOYSA-N [diacetyloxy(ethenyl)silyl] acetate Chemical compound CC(=O)O[Si](OC(C)=O)(OC(C)=O)C=C NOZAQBYNLKNDRT-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 238000007718 adhesive strength test Methods 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000004450 alkenylene group Chemical group 0.000 description 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 125000004419 alkynylene group Chemical group 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- UIJGNTRUPZPVNG-UHFFFAOYSA-N benzenecarbothioic s-acid Chemical compound SC(=O)C1=CC=CC=C1 UIJGNTRUPZPVNG-UHFFFAOYSA-N 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 1
- QUZSUMLPWDHKCJ-UHFFFAOYSA-N bisphenol A dimethacrylate Chemical compound C1=CC(OC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OC(=O)C(C)=C)C=C1 QUZSUMLPWDHKCJ-UHFFFAOYSA-N 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- FOYJYXHISWUSDL-UHFFFAOYSA-N butyl 4-(dimethylamino)benzoate Chemical compound CCCCOC(=O)C1=CC=C(N(C)C)C=C1 FOYJYXHISWUSDL-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 description 1
- 229910001634 calcium fluoride Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229930003633 citronellal Natural products 0.000 description 1
- 235000000983 citronellal Nutrition 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 239000013039 cover film Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001723 curing Methods 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000005724 cycloalkenylene group Chemical group 0.000 description 1
- OIWOHHBRDFKZNC-UHFFFAOYSA-N cyclohexyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OC1CCCCC1 OIWOHHBRDFKZNC-UHFFFAOYSA-N 0.000 description 1
- KBLWLMPSVYBVDK-UHFFFAOYSA-N cyclohexyl prop-2-enoate Chemical compound C=CC(=O)OC1CCCCC1 KBLWLMPSVYBVDK-UHFFFAOYSA-N 0.000 description 1
- VTXVGVNLYGSIAR-UHFFFAOYSA-N decane-1-thiol Chemical compound CCCCCCCCCCS VTXVGVNLYGSIAR-UHFFFAOYSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- ISAOCJYIOMOJEB-UHFFFAOYSA-N desyl alcohol Natural products C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- ZFTFAPZRGNKQPU-UHFFFAOYSA-N dicarbonic acid Chemical compound OC(=O)OC(O)=O ZFTFAPZRGNKQPU-UHFFFAOYSA-N 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- MIBMTBXKARQXFP-UHFFFAOYSA-N diphenylphosphoryl-(2,3,5,6-tetramethylphenyl)methanone Chemical compound CC1=CC(C)=C(C)C(C(=O)P(=O)(C=2C=CC=CC=2)C=2C=CC=CC=2)=C1C MIBMTBXKARQXFP-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- HFJRKMMYBMWEAD-UHFFFAOYSA-N dodecanal Chemical compound CCCCCCCCCCCC=O HFJRKMMYBMWEAD-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229910001651 emery Inorganic materials 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- MASNVFNHVJIXLL-UHFFFAOYSA-N ethenyl(ethoxy)silicon Chemical compound CCO[Si]C=C MASNVFNHVJIXLL-UHFFFAOYSA-N 0.000 description 1
- NKSJNEHGWDZZQF-UHFFFAOYSA-N ethenyl(trimethoxy)silane Chemical compound CO[Si](OC)(OC)C=C NKSJNEHGWDZZQF-UHFFFAOYSA-N 0.000 description 1
- ORBFAMHUKZLWSD-UHFFFAOYSA-N ethyl 2-(dimethylamino)benzoate Chemical compound CCOC(=O)C1=CC=CC=C1N(C)C ORBFAMHUKZLWSD-UHFFFAOYSA-N 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 239000003178 glass ionomer cement Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
- LNCPIMCVTKXXOY-UHFFFAOYSA-N hexyl 2-methylprop-2-enoate Chemical compound CCCCCCOC(=O)C(C)=C LNCPIMCVTKXXOY-UHFFFAOYSA-N 0.000 description 1
- LNMQRPPRQDGUDR-UHFFFAOYSA-N hexyl prop-2-enoate Chemical compound CCCCCCOC(=O)C=C LNMQRPPRQDGUDR-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- QQVIHTHCMHWDBS-UHFFFAOYSA-L isophthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC(C([O-])=O)=C1 QQVIHTHCMHWDBS-UHFFFAOYSA-L 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000005351 kimble Substances 0.000 description 1
- 229910052746 lanthanum Inorganic materials 0.000 description 1
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
- 229940089454 lauryl aldehyde Drugs 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000001853 liver microsome Anatomy 0.000 description 1
- 125000005641 methacryl group Chemical group 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- ZZSKMNCIAKKVRB-UHFFFAOYSA-N morpholin-4-yl-(2-nitrophenyl)methanone Chemical compound [O-][N+](=O)C1=CC=CC=C1C(=O)N1CCOCC1 ZZSKMNCIAKKVRB-UHFFFAOYSA-N 0.000 description 1
- 230000007886 mutagenicity Effects 0.000 description 1
- 231100000299 mutagenicity Toxicity 0.000 description 1
- 231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 1
- LKNDYQNNDRTHFP-UHFFFAOYSA-N n,n,3,4-tetramethylaniline Chemical compound CN(C)C1=CC=C(C)C(C)=C1 LKNDYQNNDRTHFP-UHFFFAOYSA-N 0.000 description 1
- NBFRQCOZERNGEX-UHFFFAOYSA-N n,n,3,5-tetramethylaniline Chemical compound CN(C)C1=CC(C)=CC(C)=C1 NBFRQCOZERNGEX-UHFFFAOYSA-N 0.000 description 1
- CWOMTHDOJCARBY-UHFFFAOYSA-N n,n,3-trimethylaniline Chemical compound CN(C)C1=CC=CC(C)=C1 CWOMTHDOJCARBY-UHFFFAOYSA-N 0.000 description 1
- GYVGXEWAOAAJEU-UHFFFAOYSA-N n,n,4-trimethylaniline Chemical compound CN(C)C1=CC=C(C)C=C1 GYVGXEWAOAAJEU-UHFFFAOYSA-N 0.000 description 1
- HKJNHYJTVPWVGV-UHFFFAOYSA-N n,n-diethyl-4-methylaniline Chemical compound CCN(CC)C1=CC=C(C)C=C1 HKJNHYJTVPWVGV-UHFFFAOYSA-N 0.000 description 1
- QDOHXBBRYQKICH-UHFFFAOYSA-N n,n-dimethyl-4-propylaniline Chemical compound CCCC1=CC=C(N(C)C)C=C1 QDOHXBBRYQKICH-UHFFFAOYSA-N 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 150000003961 organosilicon compounds Chemical class 0.000 description 1
- BFYJDHRWCNNYJQ-UHFFFAOYSA-N oxo-(3-oxo-3-phenylpropoxy)-(2,4,6-trimethylphenyl)phosphanium Chemical compound CC1=CC(C)=CC(C)=C1[P+](=O)OCCC(=O)C1=CC=CC=C1 BFYJDHRWCNNYJQ-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- NPUSTSBKXOLJIC-UHFFFAOYSA-N phenyl(2-prop-2-enoyloxyethoxy)phosphinic acid Chemical compound C=CC(=O)OCCOP(=O)(C1=CC=CC=C1)O NPUSTSBKXOLJIC-UHFFFAOYSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 230000000865 phosphorylative effect Effects 0.000 description 1
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
- 238000013001 point bending Methods 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920005650 polypropylene glycol diacrylate Polymers 0.000 description 1
- 229920005651 polypropylene glycol dimethacrylate Polymers 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- NHARPDSAXCBDDR-UHFFFAOYSA-N propyl 2-methylprop-2-enoate Chemical compound CCCOC(=O)C(C)=C NHARPDSAXCBDDR-UHFFFAOYSA-N 0.000 description 1
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012966 redox initiator Substances 0.000 description 1
- 239000012779 reinforcing material Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- VSIVTUIKYVGDCX-UHFFFAOYSA-M sodium;4-[2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)tetrazol-2-ium-5-yl]benzene-1,3-disulfonate Chemical compound [Na+].COC1=CC([N+]([O-])=O)=CC=C1[N+]1=NC(C=2C(=CC(=CC=2)S([O-])(=O)=O)S([O-])(=O)=O)=NN1C1=CC=C([N+]([O-])=O)C=C1 VSIVTUIKYVGDCX-UHFFFAOYSA-M 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- KUCOHFSKRZZVRO-UHFFFAOYSA-N terephthalaldehyde Chemical compound O=CC1=CC=C(C=O)C=C1 KUCOHFSKRZZVRO-UHFFFAOYSA-N 0.000 description 1
- MDDUHVRJJAFRAU-YZNNVMRBSA-N tert-butyl-[(1r,3s,5z)-3-[tert-butyl(dimethyl)silyl]oxy-5-(2-diphenylphosphorylethylidene)-4-methylidenecyclohexyl]oxy-dimethylsilane Chemical compound C1[C@@H](O[Si](C)(C)C(C)(C)C)C[C@H](O[Si](C)(C)C(C)(C)C)C(=C)\C1=C/CP(=O)(C=1C=CC=CC=1)C1=CC=CC=C1 MDDUHVRJJAFRAU-YZNNVMRBSA-N 0.000 description 1
- 238000004154 testing of material Methods 0.000 description 1
- 238000012719 thermal polymerization Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- NBOMNTLFRHMDEZ-UHFFFAOYSA-N thiosalicylic acid Chemical compound OC(=O)C1=CC=CC=C1S NBOMNTLFRHMDEZ-UHFFFAOYSA-N 0.000 description 1
- 229940103494 thiosalicylic acid Drugs 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- RUELTTOHQODFPA-UHFFFAOYSA-N toluene 2,6-diisocyanate Chemical compound CC1=C(N=C=O)C=CC=C1N=C=O RUELTTOHQODFPA-UHFFFAOYSA-N 0.000 description 1
- CMHHITPYCHHOGT-UHFFFAOYSA-N tributylborane Chemical compound CCCCB(CCCC)CCCC CMHHITPYCHHOGT-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- SRPWOOOHEPICQU-UHFFFAOYSA-N trimellitic anhydride Chemical compound OC(=O)C1=CC=C2C(=O)OC(=O)C2=C1 SRPWOOOHEPICQU-UHFFFAOYSA-N 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XASAPYQVQBKMIN-UHFFFAOYSA-K ytterbium(iii) fluoride Chemical compound F[Yb](F)F XASAPYQVQBKMIN-UHFFFAOYSA-K 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/60—Preparations for dentistry comprising organic or organo-metallic additives
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J4/00—Adhesives based on organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond ; adhesives, based on monomers of macromolecular compounds of groups C09J183/00 - C09J183/16
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/30—Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/70—Preparations for dentistry comprising inorganic additives
- A61K6/71—Fillers
- A61K6/74—Fillers comprising phosphorus-containing compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
- A61K6/831—Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
- A61K6/838—Phosphorus compounds, e.g. apatite
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/098—Esters of polyphosphoric acids or anhydrides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
- C08F222/10—Esters
- C08F222/1006—Esters of polyhydric alcohols or polyhydric phenols
- C08F222/102—Esters of polyhydric alcohols or polyhydric phenols of dialcohols, e.g. ethylene glycol di(meth)acrylate or 1,4-butanediol dimethacrylate
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J4/00—Adhesives based on organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond ; adhesives, based on monomers of macromolecular compounds of groups C09J183/00 - C09J183/16
- C09J4/06—Organic non-macromolecular compounds having at least one polymerisable carbon-to-carbon unsaturated bond in combination with a macromolecular compound other than an unsaturated polymer of groups C09J159/00 - C09J187/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F20/00—Homopolymers and copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride, ester, amide, imide or nitrile thereof
- C08F20/02—Monocarboxylic acids having less than ten carbon atoms, Derivatives thereof
- C08F20/10—Esters
- C08F20/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
- C08F20/36—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate containing oxygen in addition to the carboxy oxygen, e.g. 2-N-morpholinoethyl (meth)acrylate or 2-isocyanatoethyl (meth)acrylate
Definitions
- the present invention relates to an adhesive monomer for dental material, a dental material containing the monomer, and a kit containing the dental material.
- Non-patent document 1 From the viewpoint of MI, restoration materials with high adhesiveness to teeth, such as development of adhesive monomers that have sufficient adhesive strength, toughness, and durability in a small adhesive area, and improved tooth surface treatment methods. Development of is strongly desired.
- a typical adhesive monomer for a dental material contains a carboxylic acid or a phosphate group at the terminal, and thus acts as a coupling agent between the resin and the tooth.
- MDP (10-methoxydiphenyl) MDP
- MDP is a monofunctional monomer, there is a limit to the formation of a resin matrix, and a high strength contribution cannot be expected.
- a phosphoric acid monomer containing a plurality of acrylic groups in the molecule has been reported and an improvement in resin strength is expected.
- an object of the present invention is to provide an adhesive monomer for dental materials having a function of improving the adhesive strength with a tooth during dental treatment.
- n 1a represents the number of end groups (Y1) directly bonded to the nucleus (X), and n 1b represents a linking group (Z ), And the sum of n 1a and n 1b is equal to the valence of the core (X),
- the core part (X) contains an oxygen atom or a nitrogen atom, and a trivalent or higher polyvalent number of 1 to 200 carbon atoms in which the atom bonded to the terminal group (Y1) or the linking group (Z) is an oxygen atom or a nitrogen atom.
- the terminal group (Y1) includes a phosphorus-containing group represented by the following general formula (2), a phosphorus-containing group represented by the following general formula (3), and a (meth) acryloyl group-containing group represented by the following general formula (4) ( Y2), a (meth) acryloyl group, a hydrocarbon group having 1 to 20 carbon atoms, or a hydrogen atom, and a plurality of terminal groups (Y1) may be the same or different, provided that they are represented by the general formula (1) 1 or more is a phosphorus-containing group represented by the following general formula (2) or a phosphorus-containing group represented by the following general formula (3), and at least one ( A (meth) acryloyl group-containing group (Y2),
- the linking group (Z) is a divalent group represented by the following general formula (5). When the compound represented by the general formula (1) includes a plurality of linking groups (Z), the linking group (Z Z) may be the same or different. )
- one end of the group is bonded to the core (X) or the linking group (Z), and the other end of the group is the core contained in another compound represented by the general formula (1) ( X) or a linking group (Z).
- R 4a represents a hydrogen atom or a methyl group
- R 4b represents a linear alkylene group having 2 to 6 carbon atoms, or a linear oxyalkylene group having 2 to 6 carbon atoms
- the hydrogen atom contained in the linear alkylene group or the linear oxyalkylene group may be substituted with an alkyl group having 1 to 6 carbon atoms or a (meth) acryloyloxymethylene group.
- n 5a , n 5b , n 5c , and n 5d represent the number of units of each repeating unit, and are each 0 to 100, and n 5a , n 5b , n 5c , and n 5
- the total of 5d is 1 to 100, and the left end of the group is bonded to the nucleus (X), and the right end of the group is bonded to the terminal group (Y1).
- the terminal group (Y1) is a phosphorus-containing group represented by the general formula (2), a phosphorus-containing group represented by the general formula (3), or a (meth) acryloyl represented by the general formula (4).
- the terminal group (Y1) is a phosphorus-containing group represented by the general formula (2), a phosphorus-containing group represented by the general formula (3), or a (meth) represented by the general formula (4).
- n 5a , n 5b , n 5c , and n 5d are each 0 to 20, and the total of n 5a , n 5b , n 5c , and n 5d is 1 to 20
- n 6a , n 6b and n 6c represent the number of units of each repeating unit, and are each 0 to 20, and the total of n 6a , n 6b and n 6c is 1 to 20
- the left end of the group is bonded to the nucleus (X), and the right end of the group is bonded to the end group (Y1).
- n 7a and n 7b represent the number of units of each repeating unit, and are each 0 to 20, and the total of n 7a and n 7b is 1 to 20, (The left end is bonded to the nucleus (X), and the right end of the above group is bonded to the terminal group (Y1).)
- the adhesive monomer for dental materials according to any one of [1] to [6], wherein the core (X) is a trivalent to valent organic group.
- the core part (X) is any one of [1] to [7], wherein the core part (X) is at least one selected from the group consisting of groups represented by the following general formulas (8a) to (8j): Adhesive monomer for dental materials.
- the (meth) acryloyl group-containing group (Y2) is at least one selected from the group consisting of groups represented by the following general formulas (4a) to (4f):
- the adhesive monomer for dental material of the present invention has a function of improving the adhesive strength with the tooth during the dental treatment.
- (meth) acryl means acryl or methacryl
- (meth) acrylic acid means methacrylic acid or acrylic acid
- (meth) acryloyl means “acryloyl” or “methacryloyl”
- (meth) acrylate means “acrylate” or “methacrylate”.
- the adhesive monomer for dental material of the present invention is a compound represented by the following general formula (1) in which the following core (X) and the following end group (Y1) are bonded directly or through the following linking group (Z). is there.
- n 1a represents the number of terminal groups (Y1) directly bonded to the nucleus (X), and n 1b represents a linking group (Z) to the nucleus (X).
- n 1a and n 1b are integers of 0 or more, and the combination is not particularly limited as long as the sum thereof is 3 or more.
- n 1a is 0, n 1b is an integer of 3 or more.
- all terminal groups (Y1) are bonded to the core part X through a linking group (Z). Yes.
- n 1b is 0, n 1a is an integer of 3 or more. In this case, all end groups (Y1) are directly bonded to the nucleus X.
- the core (X) is a trivalent or higher-valent polyvalent organic group containing an oxygen atom or a nitrogen atom, and the atom bonded to the terminal group (Y1) or the linking group (Z) is an oxygen atom or a nitrogen atom. .
- the oxygen atom or nitrogen atom bonded to the terminal group (Y1) or the linking group (Z) is a group other than the terminal group (Y1) or the linking group (Z) other than a methylene group or a divalent aromatic carbon group.
- Any hydrogen atom contained in the methylene group or divalent aromatic carbon group may be replaced with a monovalent hydrocarbon group having 1 to 12 carbon atoms.
- the number of carbon atoms in the core part (X) is usually in the range of 1 to 200, preferably 1 to 100, more preferably 1 to 30, and further preferably 2 to 20.
- the valence of the core part (X) is 3 or more as described above, but it is preferably 3 to 12 valence, more preferably 3 to 8 valence.
- the atom bonded to the terminal group (Y1) or the linking group (Z) is selected from an oxygen atom or a nitrogen atom as described above, and is preferably an oxygen atom.
- Examples of the nucleus (X) include groups represented by the following general formulas (8a) to (8j).
- n 8g is an integer of 1 to 40, preferably 1 to 20, more preferably 1 to 10, and further preferably 1 to 5. .
- the terminal group (Y1) includes a phosphorus-containing group represented by the following general formula (2), a phosphorus-containing group represented by the following general formula (3), and a (meth) acryloyl group-containing group represented by the following general formula (4) ( Y2), a (meth) acryloyl group, a hydrocarbon group having 1 to 20 carbon atoms or a hydrogen atom, and a plurality of terminal groups (Y1) may be the same or different, provided that they are represented by the general formula (1) Of all the terminal groups (Y1) in the compound, one or more is a phosphorus-containing group represented by the following general formula (2) or a phosphorus-containing group represented by the following general formula (3), and one or more is (meta ) An acryloyl group-containing group (Y2).
- one end of the group is bonded to the core (X) or the linking group (Z), and the other end of the group is the core (X included in the compound represented by the other general formula (1). Or a linking group (Z).
- R 4a represents a hydrogen atom or a methyl group
- R 4b represents a linear alkylene group having 2 to 6 carbon atoms, or a linear oxyalkylene group having 2 to 6 carbon atoms
- the straight chain alkylene group or the hydrogen atom contained in the straight chain oxyalkylene group may be substituted with an alkyl group having 1 to 6 carbon atoms or a (meth) acryloyloxymethylene group.
- Examples of the (meth) acryloyl group-containing group (Y3) represented by the general formula (4) include groups represented by the following general formulas (4a) to (4f).
- the terminal group (Y1) is a phosphorus-containing group represented by the general formula (2), a phosphorus-containing group represented by the general formula (3), or a (meth) acryloyl represented by the general formula (4).
- the phosphorus-containing group represented by 3) or the (meth) acryloyl group-containing group (Y2) represented by the general formula (4) is more preferable.
- linking group (Z) is a divalent group represented by the following general formula (5).
- the linking group (Z Z) may be the same or different.
- n 5a , n 5b , n 5c , and n 5d represent the number of units of each repeating unit, and are each 0-100, preferably 0-20.
- the sum of n 5a , n 5b , n 5c , and n 5d is 1 to 100, preferably 1 to 20.
- the left end of the group is bonded to the nucleus (X), and the right end of the group is bonded to the end group (Y1).
- the repeating unit represented by —C 2 H 4 O— in the general formula (5) is an oxyethylene unit.
- the oxyethylene unit include —CH 2 CH 2 O— and —CH (CH 3 ) O—.
- —CH 2 CH 2 O— is preferable.
- These oxyethylene units may be contained singly or in combination of two or more.
- the repeating unit represented by —C 3 H 6 O— in the general formula (5) is an oxypropylene unit.
- the oxypropylene units e.g., -CH 2 CH 2 CH 2 O -, - CH (CH 3) CH 2 O-, and -CH 2 CH (CH 3) groups such as O- and the like.
- oxypropylene units —CH (CH 3 ) CH 2 O— and —CH 2 CH (CH 3 ) O— are preferable.
- These oxypropylene units may be contained singly or in combination of two or more.
- the repeating unit represented by —C 4 H 8 O— in the general formula (5) is an oxybutylene unit.
- the oxybutylene unit include —CH 2 CH 2 CH 2 CH 2 O—, —CH (CH 3 ) CH 2 CH 2 O—, —CH 2 CH (CH 3 ) CH 2 O—, —CH 2 CH 2 CH (CH 3 ) O—, —CH (CH 2 CH 3 ) CH 2 O—, —CH 2 CH (CH 2 CH 3 ) O—, —CH (CH 3 ) CH (CH 3 ) O—, And groups such as —C (CH 3 ) 2 CH 2 O— and —CH 2 C (CH 3 ) 2 O—.
- —CH 2 CH 2 CH 2 CH 2 O— is preferable.
- These oxybutylene units may be included singly or in combination of two or more.
- the repeating unit represented by —CO (CH 2 ) 5 O— in the general formula (5) is one unit of a polycaprolactone chain.
- Said repeating unit may be comprised by 1 type, and may be comprised by 2 or more types.
- the form in which these repeating units are included is not particularly limited.
- each repeating unit may be included at random, or a certain number of repeating units are fixed in a certain number. That is, each repeating unit may be included in blocks. Further, the order of these repeating units is not limited at all.
- the linking group (Z) is preferably a divalent group represented by the following general formula (6).
- the linking groups (Z) may be the same or different.
- n 6a , n 6b and n 6c represent the number of units of each repeating unit, and are each 0 to 100, preferably 0 to 20.
- the sum of n 6a , n 6b and n 6c is 1 to 100, preferably 1 to 20.
- the left end of the group is bonded to the nucleus (X), and the right end of the group is bonded to the end group (Y1).
- the description about each repeating unit in the said General formula (6) is the same as the description of each repeating unit in the said General formula (5).
- the linking group (Z) is more preferably a divalent group represented by the following general formula (7).
- the linking groups (Z) may be the same or different.
- n 7a and n 7b represent the number of units of each repeating unit, and are each 0-100, preferably 0-20.
- the total of n 7a and n 7b is 1 to 100, preferably 1 to 20.
- the left end of the group is bonded to the nucleus (X), and the right end of the group is bonded to the end group (Y1).
- the description about each repeating unit in the said General formula (7) is the same as the description of each repeating unit in the said General formula (5).
- linking group (Z) include those in which the repeating unit is composed only of oxyethylene units (in the general formula (7), n 7b is 0 and n 7a is 1 to 100, preferably Is composed of only oxypropylene units (in formula (7), n 7a is 0, n 7b is 1 to 100, preferably 1 to 20), oxy Polymer block composed of propylene units-polymer block composed of oxyethylene units-polymer block composed of oxypropylene units (in general formula (7), linked in the following structure (7 ') And the like).
- n 7a1 , n 7a2 and n 7b represent the number of units of each repeating unit, and are each 1 to 100, preferably 1 to 20.
- the total of n 7a1 , n 7a2 and n 7b is 1 to 100, preferably 1 to 20.
- the left end of the group is bonded to the core (X), the right end of the group is bonded to the end group (Y1), and the oxypropylene polymer block and the oxyethylene polymer block in parentheses are bonded in this order. is doing.
- the description about each repeating unit in the said General formula (7 ') is the same as the description of each repeating unit in the said General formula (5).
- Examples of the adhesive monomer for dental material of the present invention include compounds represented by the following general formulas (10a) to (10v).
- R 10A , R 10B , R 10C , R 10D , R 10E , R 10a , R 10b , R 10c , R 10d , R 10e , and R 10f are hydrogen atoms or It is a methyl group.
- n 10a , n 10b , n 10c , n 10d , n 10e , and n 10f represent the number of units of each repeating unit (specifically, an oxyethylene unit or an oxypropylene unit), and each range from 1 to 100 1 to 20 is preferable, and the number of units may be the same or different.
- each repeating unit may be comprised by 1 type (oxyethylene unit or oxypropylene unit), and may be comprised by these 2 types (oxyethylene unit and oxypropylene unit).
- each structural unit may be included at random, or a certain number of repeating units may be fixed, that is, each repeating unit may be included in blocks. . Further, the order of these repeating units is not limited at all.
- the adhesive monomer for dental material of the present invention can be produced by a known method.
- a corresponding hydroxyl group-containing compound or amino group-containing compound preferably a corresponding hydroxyl group-containing compound
- a known phosphorylating agent for example, phosphorus pentoxide, phosphorus pentachloride, phosphorus trichloride, phosphorus oxychloride, phosphorus pentasulfide, etc.
- a hydroxyl group or an amino group, preferably a hydroxyl group contained in the compound is phosphorylated or amidated.
- the hydroxyl group or amino group-containing compound corresponding to the adhesive monomer for dental material has the following general formula (X) and the following end group (Y3) bonded directly or via the following linking group (Z): 11).
- n 11a represents the number of end groups (Y3) directly bonded to the nucleus (X), and n 11b is bonded to the nucleus (X) via a linking group (Z).
- the sum of n 11a and n 11b is equal to the valence of the nucleus (X).
- n 11a and n 11b are integers of 0 or more, and the combination is not particularly limited as long as the sum is 3 or more. As an example of the combination, if n 11a is 0, n 11b is an integer of 3 or more. In this case, all terminal groups (Y3) are bonded to the core (X) through the linking group (Z). is doing.
- n 11b is 0, n 11a is an integer of 3 or more.
- all the end groups (Y3) are directly bonded to the core (X).
- the description of the core (X) and the linking group (Z) is as described for the general formula (1).
- the terminal group (Y3) is a (meth) acryloyl group-containing group (Y2) represented by the general formula (4), a (meth) acryloyl group, a hydrocarbon group having 1 to 20 carbon atoms, or a hydrogen atom, It is preferably a (meth) acryloyl group-containing group (Y2), (meth) acryloyl group, or hydrogen atom represented by the general formula (4), and a (meth) acryloyl group-containing group represented by the general formula (4). (Y2) or a hydrogen atom is more preferable.
- a plurality of terminal groups (Y3) may be the same or different.
- one or more is a (meth) acryloyl group-containing group (Y2), and one or more is a hydrogen atom, preferably 2 or more is a (meth) acryloyl group-containing group (Y2), and 1 or more is a hydrogen atom.
- the dental monomer adhesive monomer of the present invention is produced by the above method, all the hydroxyl groups or amino groups in the corresponding hydroxyl group or amino group-containing compound are phosphorylated or phosphoramidated. In addition, some hydroxyl groups or amino groups may remain. These products can be used as the adhesive monomer for dental materials of the present invention as long as it contains the compound represented by the general formula (1).
- the adhesive monomer for dental materials of the present invention is produced by the above method, one ester group or amide group is introduced per one phosphorus atom, or two ester groups or amides are introduced. Groups may be introduced. These products can be used as the adhesive monomer for dental materials of the present invention as long as it contains the compound represented by the general formula (1).
- R 11A , R 11B , R 11C , R 11D , R 11E , R 11a , R 11b , R 11c , R 11d , R 11e , and R 11f are a hydrogen atom or It is a methyl group.
- n 11a , n 11b , n 11c , n 11d , n 11e , and n 11f represent the number of units of each repeating unit (specifically, an oxyethylene unit or an oxypropylene unit), and each range from 1 to 100. 1 to 20 is preferable, and the number of units may be the same or different.
- each repeating unit may be comprised by 1 type (oxyethylene unit or oxypropylene unit), and may be comprised by these 2 types (oxyethylene unit and oxypropylene unit).
- each structural unit may be included at random, or a certain number of repeating units may be fixed, that is, each repeating unit may be included in blocks. . Further, the order of these repeating units is not limited at all.
- the method for producing a hydroxyl group-containing compound or an amino group-containing compound corresponding to the adhesive monomer for dental materials of the present invention is not particularly limited.
- reaction conditions such that a part of hydroxyl groups remain with respect to a polyol compound.
- a (meth) acryloyl group-containing isocyanate compound represented by the following general formula (12) is obtained by reacting a (meth) acryloyl group-containing isocyanate compound represented by the following general formula (12).
- R 12a represents a hydrogen atom or a methyl group
- R 12b represents a linear alkylene group having 2 to 6 carbon atoms, or a linear oxyalkylene group having 2 to 6 carbon atoms
- the straight chain alkylene group or the hydrogen atom contained in the straight chain oxyalkylene group may be substituted with an alkyl group having 1 to 6 carbon atoms or a (meth) acryloyloxymethylene group.
- the monomer composition for a dental material of the present invention is a polymerizable monomer other than the adhesive monomer for a dental material of the present invention that can be blended in the dental material described later (for example, ) Acrylate group-containing monomer) may or may not be contained.
- the content of the adhesive monomer for dental materials of the present invention is 1.0% by mass or more (10% by mass or more, 50% by mass) with respect to the whole monomer composition for dental materials. % Or more, 80% by mass or more, 90% by mass or more) or 100% by mass or less (99% by mass or less, 90% by mass or less, 80% by mass or less, 50% by mass or less, 10% by mass or less, etc.) Good.
- the reverse mutation test (Ames test) means a test for examining the mutagenicity of a monomer composition for dental materials using microorganisms.
- the reverse mutation test in the present invention is performed by the following method.
- the following procedure is performed under a fluorescent lamp with an ultraviolet absorbing film and / or under an LED.
- DMSO dimethyl sulfoxide
- pH 7.4 0.1 M phosphate buffer
- top agar described later is added and mixed, and overlaid on a minimum glucose agar plate medium (more than 5 doses) described later.
- a minimum glucose agar plate medium more than 5 doses described later.
- the top and bottom of the minimal glucose agar plate is inverted and cultured at 37 ° C. for 48 hours. The plate after culture is judged as negative or positive.
- DMSO is used as a negative control substance, and 0.1 mL of medium is added instead of the test composition liquid in the above step.
- the test composition is in all strains and all doses, and both in the case of non-metabolic activation and in the case of metabolic activation, compared to the case of only the negative target substance, When the average number of colonies is within 2 times, the dental material monomer composition is judged negative.
- the test substance contained in the test composition solution (specifically, the dental material adhesive monomer contained in the dental material monomer composition) has a maximum dose of 5000 ⁇ g / plate. Prepare at least 5 doses divided by a common ratio of 2-4.
- Salmonella typhimurium TA100, TA1535, Escherichia coli WP2uvrA, or frameshift mutant Salmonella typhimurium TA98 or TA1537, which is a base pair substitution mutant, is used.
- Tesmedia AN medium manufactured by Oriental Yeast Co., Ltd., for mutagenicity test
- the minimum glucose agar plate per dose should be 2 or more for the negative control substance and 2 or more for the test composition.
- the case of metabolic activation means the case where S9mix (a rat liver microsome fraction added with a coenzyme) is added together with the test substance, and the case of no metabolic activation means the case where S9mix is not added.
- the composition of S9mix is as follows: S9 (supernatant portion when the liver homogenate is centrifuged at 9000 ⁇ g): 0.1 mL, MgCl 2 : 8 ⁇ mol, KCl: 33 ⁇ mol, glucose-6-phosphate: 5 ⁇ mol, NADPH: 4 ⁇ mol, NAPH: 4 ⁇ mol, sodium phosphate buffer (pH 7.4): 100 ⁇ mol.
- Top agar was prepared by sterilizing an amino acid solution (0.5 mmol / L L-histidine, 0.5 mmol / L D-biotin, 0.5 mmol / L L-tryptophan), while soft agar solution (0.6% ( W / v) Agar (Bacto-Agar, 0.5% (w / v) sodium chloride) was autoclaved at 121 ° C. for 20 minutes, and the amino acid solution and the dissolved soft agar solution were in a volume ratio of 1:10. Use a mixture of.
- an amino acid solution 0.5 mmol / L L-histidine, 0.5 mmol / L D-biotin, 0.5 mmol / L L-tryptophan
- soft agar solution 0.6% ( W / v) Agar (Bacto-Agar, 0.5% (w / v) sodium chloride) was autoclaved at 121 ° C. for 20 minutes, and the amino acid solution and the dissolved soft
- each bacterial suspension for each bacterial cell, one prepared with a bacterial cell concentration (1 ⁇ 10 9 bacteria / mL or more) is used.
- Nutrient broth culture solution is used for culturing each cell.
- Nutrient broth culture solution is Nutrient broth no. 2 (Oxoid, Nutrient Broth No. 2) is dissolved in purified water to 2.5 wt% and autoclaved at 121 ° C. for 20 minutes for preparation.
- the monomer composition for dental materials of the present invention may have a relative cell viability within a certain range in a cytotoxicity test by the NRU method using Balb / 3T3 cells described later.
- the cytotoxicity test is performed by the following method.
- Balb / 3T3 cells (Balb / 3T3 clone A31 cells (mouse skin-derived fibroblasts)) seeded in a 96-well plate at 10,000 cells / well and pre-cultured for 25 hours, the medium in each well was removed, and the test composition was Add 0.1 mL of the test solution or negative control solution, and incubate in a CO 2 incubator for 24 hours. At this time, 12 wells are used for the negative control solution and 6 wells are used for the test solution. After culturing, each well is observed under a microscope, and after confirming cell growth, the culture solution in each well is removed and washed with 0.15 mL of PBS.
- NR culture solution After washing, 0.1 mL of NR culture solution is added and cultured for 3 hours in a CO 2 incubator for staining. After culturing, the culture solution in each well is removed and washed with 0.15 mL of PBS. 0.15 NR redissolved solution in each well? Add ml and shake with plate shaker for 10 minutes. Neutral red (NR) is dissolved in the NR redissolved solution, the absorbance at 540 nm of the solution in each well after dissolution is measured, and the average value is obtained.
- NR Neutral red
- the absorbance of the solution in the well to which the negative control solution is added is 100
- the absorbance of the solution in the well to which the test solution is added relative to the absorbance is the test composition containing the test substance (including the adhesive monomer for dental materials).
- the test solution containing the test composition is prepared by first adding the test composition to DMSO and then diluting with DMSO to prepare a DMSO solution. Thereafter, 10 ⁇ L of the above-mentioned DMSO solution is added per 2 mL of D05 culture solution described below, and mixed by stirring to prepare a test solution. The test solution is adjusted so that the test substance contained in the test composition solution (specifically, the dental material adhesive monomer contained in the dental material monomer composition) has a predetermined concentration.
- the negative control solution is prepared by adding DMSO to 0.5 V / v% to the D05 culture solution.
- D05 culture medium refers to D-MEM (Dulbecco's Modified Eagle's Medium 9, Cat No. 048-30275) containing calf serum 5 vol%, 1 mmol / L sodium pyruvate and penicillin-streptomycin-amphotericin B suspension 1 vol%. , Glutamine 584 mg / L and HEPES 5.958 g / L).
- the D10 culture medium refers to D-MEM containing calf serum 10 vol%, penicillin-streptomycin-amphotericin B suspension 1 vol%, 100 mmol / L sodium pyruvate solution 1 vol%.
- the NR culture solution refers to a mixture obtained by mixing NR (neutral red) stock solution and D10 culture solution at 1:79, leaving at 37 ° C. overnight, and then removing NR crystals by filter filtration.
- the NR (neutral red) stock solution refers to a 0.4% (w / v) aqueous solution of neutral red (NR) (manufactured by Wako Pure Chemical Industries, Ltd.).
- the NR redissolved solution refers to a mixture of acetic acid, ethanol and water at 1:50:49. Prepare within 1 hour before use.
- the concentration of the test substance contained in the test composition in the test solution is, for example, 0.00164 mg / mL, 0.00410 mg / mL, 0.0102 mg / mL, 0.0256 mg / mL, 0.0640 mg / mL, It may be 0.160 mg / mL, 0.400 mg / mL, or 1.00 mg / mL.
- the concentration of the test substance contained in the test composition in the test solution is 0.00164 mg / mL, 0.00410 mg / mL, 0.0102 mg / mL, 0.0256 mg / mL, 0.0640 mg / mL, 0.160 mg / mL , 0.400 mg / mL or 1.00 mg / mL
- the relative cell viability by the NRU method using the BALB / 3T3 cells is 0.01% or more (0.05% or more, 0.1% or more 0.5% or more, 1.0% or more, 5.0% or more, 10% or more, 20% or more, 30% or more, 40% or more, 50% or more, 60% or more, 70% or more, 80% or more 90% or more, 95% or more, 99% or more, etc.) and 100% or less (99% or less, 95% or less, 90% or less, 80% or less, 70% or less, 60% or less, 50% or less) 40% or less, 30% Lower than 20%, 10% or less, 5.0% or less, 1.0% or less, 0.
- the monomer composition for dental materials of the present invention may have a relative cell growth rate within a certain range in a cell test by the WST method using Balb / 3T3 cells.
- the cell test is performed by the following method.
- Balb / 3T3 cells (Balb / 3T3 clone A31 cells (mouse skin-derived fibroblasts)) seeded in a 96-well plate at 2000 cells / well and pre-cultured for 24 hours, the culture solution in each well was removed, and the test composition Add 0.1 mL of the test solution or negative control solution, and incubate in a CO 2 incubator for 48 hours. At this time, 6 wells are used for the negative control solution and 3 wells are used for the test solution.
- the test solution or negative control solution is discarded, washed with PBS, 0.2 mL of DMEM culture solution containing 10% WST-8 reagent is added to each well, and a color reaction is performed in a CO 2 incubator for 2 hours. .
- the absorbance at 450 nm and 650 nm was measured with a microplate reader, and the value obtained by subtracting the 650 nm absorbance from the 450 nm absorbance of the liquid in each well was defined as the absorbance of each well, and the value was negative. If this is the case, the average absorbance is determined as 0.
- test composition containing the test substance (dental containing the adhesive monomer for dental material)
- relative cell growth rate (%) of the monomer composition for material).
- the test solution containing the test composition is prepared by first adding the test composition to DMSO and then diluting with DMSO to prepare a DMSO solution. Thereafter, 5 ⁇ L of DMSO diluted solution per 1 mL of DMEM culture solution is added to prepare a test solution. The test solution is adjusted so that the test substance contained in the test composition solution (specifically, the dental material adhesive monomer contained in the dental material monomer composition) has a predetermined concentration.
- the negative control solution is prepared by adding DMSO to 0.5 vol% with the DMEM culture solution.
- the DMEM culture medium refers to Dulbecco's Modified Eagle's Medium (D-MEM) containing 10 vol% calf serum and 1 vol% penicillin-streptomycin-amphotericin B suspension (x100).
- D-MEM Dulbecco's Modified Eagle's Medium
- x100 penicillin-streptomycin-amphotericin B suspension
- the concentration of the test substance contained in the test composition in the test solution is, for example, 0.00164 mg / mL, 0.00410 mg / mL, 0.0102 mg / mL, 0.0256 mg / mL, 0.0640 mg / mL, It may be 0.160 mg / mL, 0.400 mg / mL, or 1.00 mg / mL.
- the concentration of the test substance contained in the test composition in the test solution is 0.00164 mg / mL, 0.00410 mg / mL, 0.0102 mg / mL, 0.0256 mg / mL, 0.0640 mg / mL, 0.160 mg / mL , 0.400 mg / mL or 1.00 mg / mL
- the relative cell growth inhibition rate by the WST method using the BALB / 3T3 cells is 0.001% or more (0.01% or more, 0.05% Or more, 0.1% or more, 0.5% or more, 1.0% or more, 5.0% or more, 10% or more, 20% or more, 30% or more, 40% or more, 50% or more, 60% or more, 70% or more, 80% or more, 90% or more, 95% or more, 99% or more, etc.) and 100% or less (99% or less, 95% or less, 90% or less, 80% or less, 70% or less, 60% or less, 50% or less 40% or less, 30% or less, 20% or less, 10% or less,
- the adhesive monomer for dental material of the present invention improves the adhesive strength with the tooth during dental treatment while giving sufficient mechanical strength to the cured material of the dental material containing the adhesive monomer for dental material of the present invention. Therefore, it is suitable as a raw material for dental materials.
- Components other than the adhesive monomer for dental material of the present invention for example, polymerizable monomers other than the adhesive monomer for dental material of the present invention (for the dental material of the present invention)
- a dental material containing the dental material adhesive monomer of the present invention can be produced.
- (Meth) acrylate group-containing monomer other than the adhesive monomer for dental material of the present invention As an example of components other than the adhesive monomer for dental materials of this invention, (meth) acrylate group containing monomers other than the adhesive monomer for dental materials of this invention can be mentioned.
- the (meth) acrylate group-containing monomer other than the adhesive monomer for dental material of the present invention includes one or more (meth) acrylate groups in the molecule.
- the number of polymerizable groups contained may be one, or two or more.
- the (meth) acrylate group-containing monomer other than the above-mentioned adhesive monomer for dental materials of the present invention may be composed of one compound or a mixture of two or more compounds.
- Examples of the (meth) acrylate group-containing monomer other than the above-mentioned adhesive monomer for dental materials having only one polymerizable group include a monomer represented by the following general formula (21).
- R 21a represents hydrogen or a methyl group
- R 21b represents a monovalent organic group having 1 to 20 carbon atoms which may contain oxygen or nitrogen.
- Examples of the monovalent organic group include carbon atoms such as an acyclic hydrocarbon group having 1 to 20 carbon atoms such as an alkyl group, an alkenyl group, and an alkynyl group, a cycloalkyl group, a cycloalkenyl group, a cycloalkynyl group, and an aryl group.
- Hydrocarbon groups such as cyclic hydrocarbon groups of 1 to 20; oxygen is inserted between at least some carbon-carbon bonds of the above hydrocarbon groups such as alkoxyalkyl groups, alkoxyalkylene glycol groups, and tetrahydrofurfuryl groups.
- an oxygen-containing hydrocarbon group having 1 to 20 carbon atoms such as a group formed (provided that oxygen is not continuously inserted).
- the cyclic hydrocarbon group having 1 to 20 carbon atoms may have an acyclic hydrocarbon portion. Further, the acyclic hydrocarbon moiety contained in these groups may be either linear or branched.
- the hydrocarbon group having 1 to 20 carbon atoms or the oxygen-containing hydrocarbon group having 1 to 20 carbon atoms contains a linear alkylene moiety
- at least one methylene group is an ester bond, an amide
- the bond, carbonate bond, urethane bond (carbamoyl group), or urea bond may be substituted (however, the methylene group is not continuously replaced).
- a hydrogen atom contained in the organic group such as a hydrocarbon group having 1 to 20 carbon atoms or an oxygen-containing hydrocarbon group having 1 to 20 carbon atoms is an acid group such as a carboxyl group or a phosphate group, a hydroxyl group, or an amino group. , May be replaced with a functional group such as an epoxy group.
- Examples of the compound having a methacryloyl group represented by the general formula (21) include methyl methacrylate, ethyl methacrylate, propyl methacrylate, butyl methacrylate, hexyl methacrylate, cyclohexyl methacrylate, ethoxydiethylene glycol methacrylate, methoxytriethylene glycol methacrylate, and phenoxyethyl.
- Examples include methacrylate, 2-hydroxyethyl methacrylate, 2-hydroxypropyl methacrylate, 2-hydroxybutyl methacrylate, 2-hydroxy-3-phenoxypropyl methacrylate, 4-hydroxybutyl methacrylate, and 1,4-cyclohexanedimethanol monomethacrylate.
- Examples of the compound having an acryloyl group represented by the general formula (21) include methyl acrylate, ethyl acrylate, propyl acrylate, butyl acrylate, hexyl acrylate, cyclohexyl acrylate, ethoxydiethylene glycol acrylate, methoxytriethylene glycol acrylate, and phenoxyethyl.
- Examples include acrylate, 2-hydroxyethyl acrylate, 2-hydroxypropyl acrylate, 2-hydroxybutyl acrylate, 2-hydroxy-3-phenoxypropyl acrylate, 4-hydroxybutyl acrylate, and 1,4-cyclohexanedimethanol monoacrylate.
- Examples of the (meth) acrylate group-containing monomer other than the adhesive monomer for dental materials of the present invention having two or more polymerizable groups include monomers represented by the following general formula (22).
- R 22a and R 22b represent hydrogen or a methyl group, which may be the same or different, and R 22c may contain oxygen or nitrogen.
- a valent organic group In the general formula (22), R 22a and R 22b represent hydrogen or a methyl group, which may be the same or different, and R 22c may contain oxygen or nitrogen.
- a valent organic group In the general formula (22), R 22a and R 22b represent hydrogen or a methyl group, which may be the same or different, and R 22c may contain oxygen or nitrogen.
- a valent organic group may be used in the general formula (22).
- Examples of the divalent organic group include an acyclic hydrocarbon group having 1 to 40 carbon atoms such as an alkylene group, an alkenylene group and an alkynylene group, a cycloalkylene group, a cycloalkenylene group, a cycloalkynylene group and an arylene group.
- a hydrocarbon group such as a cyclic hydrocarbon group having 1 to 40 carbon atoms; a group in which oxygen is inserted between at least some carbon-carbon bonds of the hydrocarbon group such as an oxyalkylene group (provided that oxygen is continuous) Or an oxygen-containing hydrocarbon group having 1 to 40 carbon atoms.
- the cyclic hydrocarbon group having 1 to 40 carbon atoms may have an acyclic hydrocarbon portion. Further, the acyclic hydrocarbon moiety contained in these groups may be either linear or branched.
- the hydrocarbon group having 1 to 40 carbon atoms or the oxygen-containing hydrocarbon group having 1 to 40 carbon atoms contains a linear alkylene moiety
- at least one methylene group is an ester bond, an amide
- the bond, carbonate bond, urethane bond (carbamoyl group), or urea bond may be substituted (however, the methylene group is not continuously replaced).
- a hydrogen atom contained in the organic group such as a hydrocarbon group having 1 to 40 carbon atoms or an oxygen-containing hydrocarbon group having 1 to 40 carbon atoms is an acid group such as a carboxyl group or a phosphate group, a hydroxyl group, an amino group.
- a functional group such as an epoxy group, or a polymerizable group such as an acryloyl group or a methacryloyl group.
- an example of a suitable monomer is a monomer in which R 22c is a linear alkylene group having 2 to 20 carbon atoms, preferably 4 to 12 carbon atoms.
- Examples of the suitable monomer having a methacryloyl group include 1,4-butanediol dimethacrylate, 1,6-hexanediol dimethacrylate, 1,8-octanediol dimethacrylate, and 1,9-nonanediol. Examples include dimethacrylate and 1,10-decanediol dimethacrylate.
- Examples of the compound having an acryloyl group as the preferred monomer include 1,4-butanediol diacrylate, 1,6-hexanediol diacrylate, 1,8-octanediol diacrylate, and 1,9-nonanediol. Examples include diacrylate and 1,10-decanediol diacrylate.
- R 22C is a linear oxyalkylene group having 2 to 20 carbon atoms, preferably 4 to 12 carbon atoms. Monomer.
- Examples of the compound having a methacryloyl group as the above preferred monomer include ethylene glycol dimethacrylate, diethylene glycol dimethacrylate, triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, polyethylene glycol dimethacrylate, tripropylene glycol dimethacrylate, tetra Examples include propylene glycol dimethacrylate and polypropylene glycol dimethacrylate.
- Examples of the compound having an acryloyl group as the above preferred monomer include ethylene glycol diacrylate, diethylene glycol diacrylate, triethylene glycol diacrylate, tetraethylene glycol diacrylate, polyethylene glycol diacrylate, tripropylene glycol diacrylate, tetra Examples include propylene glycol diacrylate and polypropylene glycol diacrylate.
- Suitable monomers include monomers having a carbamoyl group represented by the following general formula (23).
- R 23a and R 23b are hydrogen or a methyl group, which may be the same or different, and R 23c and R 23d may contain oxygen and have 1 to 12 carbon atoms. These are divalent organic groups, and these may be the same or different.
- Examples of the divalent organic group include hydrocarbon groups such as an acyclic hydrocarbon group having 1 to 12 carbon atoms such as an alkylene group, a cyclic hydrocarbon group having 1 to 12 carbon atoms such as a cycloalkylene group and an arylene group.
- the cyclic hydrocarbon group having 1 to 12 carbon atoms may have an acyclic hydrocarbon portion. Further, the acyclic hydrocarbon moiety contained in these groups may be either linear or branched.
- a hydrogen atom contained in the organic group such as the hydrocarbon group having 1 to 12 carbon atoms or the oxygen-containing hydrocarbon group having 1 to 12 carbon atoms is an acid group such as a carboxyl group or a phosphate group, a hydroxyl group, an amino group.
- a functional group such as an epoxy group, or a polymerizable group such as an acryloyl group or a methacryloyl group.
- R 23e represents a divalent organic group having 1 to 20 carbon atoms which may contain oxygen.
- the divalent organic group include hydrocarbon groups such as an acyclic hydrocarbon group having 1 to 20 carbon atoms such as an alkylene group, a cyclic hydrocarbon group having 1 to 20 carbon atoms such as a cycloalkylene group and an arylene group.
- a group in which oxygen is inserted between at least some carbon-carbon bonds of the hydrocarbon group such as an oxyalkylene group (however, oxygen is not continuously inserted) 1 to Examples include 20 oxygen-containing hydrocarbon groups.
- the cyclic hydrocarbon group having 1 to 20 carbon atoms may have an acyclic hydrocarbon portion. Further, the acyclic hydrocarbon moiety contained in these groups may be either linear or branched.
- a hydrogen atom contained in the organic group such as the hydrocarbon group having 1 to 20 carbon atoms or the oxygen-containing hydrocarbon group having 1 to 20 carbon atoms is an acid group such as a carboxyl group or a phosphoric acid group, a hydroxyl group, or an amino group. , May be replaced with a functional group such as an epoxy group.
- Examples of the compound having an acryloyl group represented by the general formula (23) include 2-hydroxyethyl acrylate, 2-hydroxypropyl acrylate, 2-hydroxybutyl acrylate, 2-hydroxy-3-phenoxypropyl acrylate, 4-hydroxy Hydroxy acrylate such as butyl acrylate or 1,4-cyclohexanedimethanol monoacrylate and 2,4- or 2,6-toluene diisocyanate, 4,4'-, 2,4'- or 2,2'-diphenylmethane Urethane acrylate which is a reaction product with diisocyanate such as diisocyanate, 1,6-hexamethylene diisocyanate, 2,2,4- or 2,4,4-trimethyl-1,6-hexamethylene diisocyanate, etc. It is, as such urethane acrylates, such as 2,2,4-trimethylhexamethylene bis (2-carbamoyloxy-ethyl) diacrylate.
- Another preferred example of the compound having a (meth) acryloyl group represented by the general formula (23) is at least one selected from the group consisting of compounds represented by the following general formulas (24a) to (24e) One can mention.
- Another example of the monomer represented by the general formula (22) is preferably a monomer represented by the following general formula (25).
- R 25a and R 25b represent hydrogen or a methyl group, which may be the same or different, and R 25c and R 25d may contain oxygen and have 1 to 12 carbon atoms.
- a divalent organic group which may be the same or different; Examples of the divalent organic group include hydrocarbon groups such as an acyclic hydrocarbon group having 1 to 12 carbon atoms such as an alkylene group, a cyclic hydrocarbon group having 1 to 12 carbon atoms such as a cycloalkylene group and an arylene group.
- a group in which oxygen is inserted between at least some carbon-carbon bonds of the hydrocarbon group such as an oxyalkylene group (however, oxygen is not continuously inserted) 1 to And 12 oxygen-containing hydrocarbon groups.
- the cyclic hydrocarbon group having 1 to 12 carbon atoms may have an acyclic hydrocarbon portion. Further, the acyclic hydrocarbon moiety contained in these groups may be either linear or branched.
- a hydrogen atom contained in the organic group such as the hydrocarbon group having 1 to 12 carbon atoms or the oxygen-containing hydrocarbon group having 1 to 12 carbon atoms is an acid group such as a carboxyl group or a phosphate group, a hydroxyl group, an amino group.
- a functional group such as an epoxy group, or a polymerizable group such as an acryloyl group or a methacryloyl group.
- R 25e represents a divalent organic group having 1 to 20 carbon atoms which may contain oxygen.
- the divalent organic group include a hydrocarbon group having 1 to 20 carbon atoms such as an alkylene group, a cycloalkylene group, and an arylene group; a carbon-carbon bond of at least a part of the hydrocarbon group such as an oxyalkylene group.
- an oxygen-containing hydrocarbon group having 1 to 20 carbon atoms such as a group in which oxygen is inserted (however, oxygen is not continuously inserted).
- the cyclic hydrocarbon group having 1 to 20 carbon atoms may have an acyclic hydrocarbon portion.
- a hydrogen atom contained in the organic group such as a hydrocarbon group having 1 to 20 carbon atoms or an oxygen-containing hydrocarbon group having 1 to 20 carbon atoms is an acid group such as a carboxyl group or a phosphate group, a hydroxyl group, or an amino group. , May be replaced with a functional group such as an epoxy group.
- Examples of the compound having a methacryloyl group represented by the general formula (25) include 2,2-bis [4- (3-methacryloyloxy-2-hydroxypropoxy) phenyl] propane (Bis-GMA), ethylene oxide modified Examples thereof include bisphenol A dimethacrylate and propylene oxide-modified bisphenol A dimethacrylate.
- Examples of the compound having an acryloyl group represented by the general formula (25) include 2,2-bis [4- (3-acryloyloxy-2-hydroxypropoxy) phenyl] propane, ethylene oxide-modified bisphenol A diacrylate, Examples include propylene oxide-modified bisphenol A diacrylate.
- the (meth) acrylate group-containing monomer other than the adhesive monomer for dental materials of the present invention is used.
- a monomer that exhibits an adhesion function may be contained.
- the (meth) acrylate group-containing monomer that exhibits an adhesion function other than the dental material adhesive monomer of the present invention include, for example, at least one polymerizable group selected from a methacryloyl group and an acryloyl group and an acidic group.
- the acidic group include a phosphoric acid residue, a pyrophosphoric acid residue, a thiophosphoric acid residue, a carboxylic acid residue, and a sulfonic acid residue.
- Examples of the monomer having a methacryloyl group and a phosphoric acid residue include, for example, 2-methacryloyloxyethyl dihydrogen phosphate, 9-methacryloyloxynonyl dihydrogen phosphate.
- Examples of the monomer having an acryloyl group and a phosphate residue include, for example, 2-acryloyloxyethyl dihydrogen phosphate, 9-acryloyloxynonyl dihydrogen phosphate.
- Examples of the monomer having a methacryloyl group and a pyrophosphate residue include di (2-methacryloyloxyethyl) pyrophosphate and acid chlorides thereof.
- Examples of the monomer having an acryloyl group and a pyrophosphate residue include di (2-acryloyloxyethyl) pyrophosphate and acid chlorides thereof.
- Examples of the monomer having a methacryloyl group and a thiophosphoric acid residue include 2-methacryloyloxyethyl dihydrogen dithiophosphate, 10-methacryloyloxydecyl dihydrogen thiophosphate, and acid chlorides thereof.
- Examples of the monomer having an acryloyl group and a thiophosphate residue include 2-acryloyloxyethyl dihydrogen dithiophosphate, 10-acryloyloxydecyl dihydrogen thiophosphate, and acid chlorides thereof.
- Examples of the monomer having a methacryloyl group and a carboxylic acid residue include, for example, 4-methacryloyloxyethoxycarbonylphthalic acid, 5-methacryloylaminopentylcarboxylic acid and 11-methacryloyloxy-1,1-undecanedicarboxylic acid, and acids thereof Examples include chloride or acid anhydride.
- Examples of the monomer having an acryloyl group and a carboxylic acid residue include 4-acryloyloxyethoxycarbonylphthalic acid, 5-acryloylaminopentylcarboxylic acid and 11-acryloyloxy-1,1-undecanedicarboxylic acid, and acids thereof. Examples include chloride or acid anhydride.
- Examples of the monomer having a methacryloyl group and a sulfonic acid residue include 2-sulfoethyl methacrylate and 2-methacrylamide-2-methylpropanesulfonic acid.
- Examples of the monomer having an acryloyl group and a sulfonic acid residue include 2-sulfoethyl acrylate and 2-acrylamido-2-methylpropanesulfonic acid.
- a polymerization initiator can be mentioned as another example of components other than the adhesive monomer for dental materials of the present invention contained in the dental material of the present invention.
- the polymerization initiator may be a general polymerization initiator used in the dental field, and is usually selected in consideration of the polymerizability of the polymerizable monomer and the polymerization conditions.
- a redox polymerization initiator in which an oxidizing agent and a reducing agent are combined is suitable.
- a redox polymerization initiator it is necessary to take a form in which an oxidizing agent and a reducing agent are separately packaged and to mix both of them immediately before use.
- oxidizing agent examples include, but are not limited to, organic peroxides such as diacyl peroxides, peroxyesters, dialkyl peroxides, peroxyketals, ketone peroxides, and hydroperoxides. Can do.
- organic peroxide examples include diacyl peroxides such as benzoyl peroxide, 2,4-dichlorobenzoyl peroxide and m-toluoyl peroxide; t-butylperoxybenzoate, bis-t-butylperoxy Peroxyesters such as isophthalate, 2,5-dimethyl-2,5-bis (benzoylperoxy) hexane, t-butylperoxy-2-ethylhexanoate and t-butylperoxyisopropylcarbonate; dicumyl Dialkyl peroxides such as peroxide, di-t-butyl peroxide and lauroyl peroxide; peroxyketals such as 1,1-bis (t-butylperoxy) -3,3,5-trimethylcyclohexane; methyl ethyl ketone Paoki Ketone peroxides such as id, etc. hydroperoxide such as t- butyl
- the reducing agent is not particularly limited, but usually a tertiary amine is used.
- Tertiary amines include, for example, N, N-dimethylaniline, N, N-dimethyl-p-toluidine, N, N-dimethyl-m-toluidine, N, N-diethyl-p-toluidine, N, N— Dimethyl-3,5-dimethylaniline, N, N-dimethyl-3,4-dimethylaniline, N, N-dimethyl-4-ethylaniline, N, N-dimethyl-4-i-propylaniline, N, N- Dimethyl-4-t-butylaniline, N, N-dimethyl-3,5-di-t-butylaniline, N, N-bis (2-hydroxyethyl) -p-toluidine, N, N-bis (2- Hydroxyethyl) -3,5-dimethylaniline, N, N-bis (2-hydroxyeth
- redox systems such as cumene hydroperoxide / thiourea system, ascorbic acid / Cu 2+ salt system, organic peroxide / amine / sulfinic acid (or its salt) system, etc.
- a polymerization initiator can be used.
- tributylborane, organic sulfinic acid and the like are also preferably used as the polymerization initiator.
- a peroxide or an azo compound In the case of performing thermal polymerization by heating, it is preferable to use a peroxide or an azo compound.
- the peroxide is not particularly limited, and examples thereof include benzoyl peroxide, t-butyl hydroperoxide, cumene hydroperoxide and the like.
- the azo compound is not particularly limited, and examples thereof include azobisisobutyronitrile.
- redox initiators such as ⁇ -diketone / tertiary amine, ⁇ -diketone / aldehyde, ⁇ -diketone / mercaptan are preferable.
- the photopolymerization initiator is not particularly limited, and examples thereof include ⁇ -diketone / reducing agent, ketal / reducing agent, and thioxanthone / reducing agent.
- examples of the ⁇ -diketone include camphorquinone, benzyl and 2,3-pentanedione.
- the ketal include benzyl dimethyl ketal and benzyl diethyl ketal.
- Examples of thioxanthone include 2-chlorothioxanthone and 2,4-diethylthioxanthone.
- Examples of the reducing agent include Mihira-ketone, 2- (dimethylamino) ethyl methacrylate, N, N-bis [(meth) acryloyloxyethyl] -N-methylamine, ethyl N, N-dimethylaminobenzoate, Butyl 4-dimethylaminobenzoate, butoxyethyl 4-dimethylaminobenzoate, N-methyldiethanolamine, 4-dimethylaminobenzophenone, N, N-bis (2-hydroxyethyl) -p-toluidine, dimethylaminophenanthol, etc.
- An ⁇ -diketone / organic peroxide / reducing agent system obtained by adding an organic peroxide to these redox systems is also preferably used.
- benzoin alkyl ether In the case of performing photopolymerization by ultraviolet irradiation, benzoin alkyl ether, benzyl dimethyl ketal and the like are suitable.
- a photopolymerization initiator of (bis) acylphosphine oxides is also preferably used.
- examples of the acylphosphine oxides include 2,4,6-trimethylbenzoyldiphenylphosphine oxide, 2,6-dimethoxybenzoyldiphenylphosphine oxide, and 2,6-dichlorobenzoyldiphenyl.
- bisacylphosphine oxides include bis- (2,6-dichlorobenzoyl) phenylphosphine oxide, bis- (2,6-dichlorobenzoyl) -2,5-dimethylphenylphosphine oxide, bis- ( 2,6-dichlorobenzoyl) -4-propylphenylphosphine oxide, bis- (2,6-dichlorobenzoyl) -1-naphthylphosphine oxide, bis- (2,6-dimethoxybenzoyl) phenylphosphine oxide, bis -(2,6-dimethoxybenzoyl) -2,4,4-trimethylpentylphosphine oxide, bis- (2,6-dimethoxybenzoyl) -2,5-dimethylphenylphosphine oxide, bis- (2,4,4) 6-Trimethylbenzoyl) phenyl Such as scan fins oxide and (2,5,6-trimethylbenzo
- acylphosphine oxide photopolymerization initiators can be used alone or in combination with reducing agents such as various amines, aldehydes, mercaptans and sulfinates. These can be suitably used in combination with the visible light photopolymerization initiator.
- the polymerization initiator or the photopolymerization initiator can be used alone or in combination of two or more, and the blending amount is usually 0.01 to 20 parts by weight, preferably 100 parts by weight with respect to 100 parts by weight of the dental material. It is used in the range of 0.1 to 5 parts by weight.
- a filler can be mentioned as another example of components other than the adhesive monomer for dental materials of this invention contained in the dental material of this invention.
- filler a general filler used in the dental field can be used.
- Fillers are generally divided into organic fillers and inorganic fillers.
- the organic filler include polymethyl methacrylate, polyethyl methacrylate, methyl methacrylate-ethyl methacrylate copolymer, crosslinked polymethyl methacrylate, crosslinked polyethyl methacrylate, ethylene-vinyl acetate copolymer, and Examples thereof include fine powders such as styrene-butadiene copolymer.
- the inorganic filler examples include various glasses (mainly composed of silicon dioxide, containing oxides such as heavy metals, boron and aluminum as necessary), various ceramics, diatomaceous earth, kaolin, clay mineral (montmorillonite, etc.). And fine powders such as activated clay, synthetic zeolite, mica, calcium fluoride, ytterbium fluoride, calcium phosphate, barium sulfate, zirconium dioxide, titanium dioxide, and hydroxyapatite.
- glasses mainly composed of silicon dioxide, containing oxides such as heavy metals, boron and aluminum as necessary
- various ceramics diatomaceous earth, kaolin, clay mineral (montmorillonite, etc.).
- fine powders such as activated clay, synthetic zeolite, mica, calcium fluoride, ytterbium fluoride, calcium phosphate, barium sulfate, zirconium dioxide, titanium dioxide, and hydroxyapatite.
- fine powders such as activated clay, synthetic
- Examples of the X-ray contrast agent include barium borosilicate glass (such as Kimble Raysorb T3000, Shot 8235, Shot GM27884 and Shot GM39923), strontium boroaluminosilicate glass (such as Raysorb T4000, Shot G018-093 and Shot GM32087), and lanthanum Glass (such as shot GM31684), fluoroaluminosilicate glass (such as shot G018-091 and shot G0188-117), boroaluminosilicate glass containing zirconium and / or cesium (such as shot G018-307, G018-308 and G018-310) Is mentioned.
- barium borosilicate glass such as Kimble Raysorb T3000, Shot 8235, Shot GM27884 and Shot GM39923
- strontium boroaluminosilicate glass such as Raysorb T4000, Shot G018-093 and Shot GM32087
- lanthanum Glass such as shot
- an organic-inorganic composite filler obtained by adding a polymerizable monomer to these inorganic fillers in advance to form a paste, polymerizing and curing, and pulverizing may be used.
- a dental material containing a microfiller having a particle size of 0.1 ⁇ m or less is one of the preferred embodiments for a dental composite resin.
- silica for example, trade name Aerosil
- alumina for example, trade name Aerosil
- zirconia, titania and the like are preferable.
- the blending of such an inorganic filler having a small particle diameter is advantageous in obtaining polishing smoothness of the cured composite resin.
- These fillers may be subjected to surface treatment with a silane coupling agent or the like depending on the purpose.
- a silane coupling agent examples include known silane coupling agents such as ⁇ -methacryloxyalkyltrimethoxysilane (carbon number between methacryloxy group and silicon atom: 3 to 12), ⁇ -methacryloxyalkyltriethoxy.
- Organosilicon compounds such as silane (carbon number between methacryloxy group and silicon atom: 3 to 12), vinyltrimethoxysilane, vinylethoxysilane and vinyltriacetoxysilane are used.
- the concentration of the surface treatment agent is usually 0.1 to 20 parts by weight, preferably 1 to 10 parts by weight, based on 100 parts by weight of the filler.
- fillers can be appropriately added depending on the use of the dental material. When these fillers are used, these fillers are appropriately used alone or in combination of two or more.
- the preferable range of the filler content varies depending on the application.
- a dental bonding material which is one of dental adhesive materials
- about 0.1 to 5 parts by weight may be contained in 100 parts by weight of the dental material.
- a dental adhesive cement which is one of dental adhesives
- 30 to 70 parts by weight in 100 parts by weight of dental material is used for improving mechanical strength and adjusting consistency. May be contained to some extent.
- a dental adhesive composite resin which is one of dental adhesives
- 50 to 90 parts in 100 parts by weight of dental material is used for improving mechanical strength and adjusting the consistency. It may be contained in about parts by weight.
- the dental material of the present invention may be a polymerizable monomer other than the above-mentioned adhesive monomer for dental material of the present invention or the adhesive monomer for dental material of the present invention (for example, Components other than the acrylate group-containing monomer, the monomer having an epoxy group), the polymerization initiator, and the filler may be appropriately included depending on the purpose.
- the polymerization inhibitor already described above may be included to improve storage stability.
- pigments such as a well-known pigment and dye, can be included.
- a known reinforcing material such as fiber may be included.
- a solvent such as acetone, ethanol, or water may be included as necessary.
- the blending amount of the adhesive monomer for dental material of the present invention in the dental material is not particularly limited, but is, for example, in the range of 0.1 to 99%.
- the preferred blending amount may vary depending on the use for the dental material.
- a polymerizable monomer component a polymerizable monomer other than the above-mentioned dental material hydroxyl group-containing monomer and the above dental material hydroxyl group-containing monomer (for example, 1 to 60% by weight is blended in the (meth) acrylate group-containing monomer other than the adhesive monomer for dental material of the present invention, and an epoxy group-containing monomer.
- Adhesive resin cement, adhesive composite resin for filling), dental primer, and dental fissure sealant the amount of the adhesive monomer for dental material should be 1 to 60% by weight in the polymerizable monomer component Is preferred.
- Reversion mutation test It is desirable that the dental material of the present invention is negative in the reverse mutation test.
- the test method of the reverse mutation test (Ames test) is carried out in the same procedure as described above, except that the monomer composition for dental material of the present invention is replaced with the dental material of the present invention.
- the dental material of the present invention may have a relative cell viability within a certain range in a cell test by the NRU method using Balb / 3T3 cells.
- the cell test is performed in the same procedure as described above except that the dental material monomer composition of the present invention is replaced with the dental material of the present invention in the above-described cell test by the NRU method.
- the concentration of the test substance contained in the test material (adhesive monomer for dental material contained in the dental material) in the test solution and the relative cell growth rate (%) of the dental material are the above-described monomer for dental material of the present invention. It may be the same as in the case of the composition.
- the dental material of the present invention may have a relative cell growth rate within a certain range in a cell test by the WST method using Balb / 3T3 cells.
- the cell test is carried out in the same procedure as described above, except that the dental material monomer composition of the present invention is replaced with the dental material of the present invention.
- the concentration of the test substance contained in the test material adheresive monomer for dental material () contained in the dental material () in the test solution and the relative cell growth rate (%) of the dental material are those for the dental material of the present invention described above. It may be the same as in the case of the monomer composition.
- the method for producing the dental material of the present invention by mixing a monomer having a group), a polymerization initiator, a filler, other components and the like is not particularly limited as long as it is a known method.
- the dental material of the present invention can be cured under appropriate conditions according to the polymerization method of the polymerization initiator described above.
- the dental material of the present invention containing a photopolymerization initiator by visible light irradiation after processing the dental material into a predetermined shape, visible light is irradiated for a predetermined time using a known light irradiation device. By irradiation, a desired cured product can be obtained. Conditions such as irradiation intensity and irradiation intensity can be appropriately changed according to the curability of the dental material.
- the mechanical properties of the cured product can be improved by further heat-treating the cured product that has been cured by light irradiation, such as visible light, under appropriate conditions.
- the dental material of the present invention containing a polymerization initiator by heating the dental material is processed into a predetermined shape and then heated to an appropriate temperature and time to obtain a desired material.
- a cured product can be obtained.
- the cured product of the dental material of the present invention obtained as described above may be used for dental treatment.
- the dental material in the present invention can be suitably used for dental treatment applications, for example, a filling composite resin, a hard crown resin, a denture base resin, a denture base lining material, an impression material, and a dental adhesive.
- a filling composite resin for example, a filling composite resin, a hard crown resin, a denture base resin, a denture base lining material, an impression material, and a dental adhesive.
- dental primer dental fissure sealant
- CAD / CAM resin block temporary crown
- artificial tooth materials Since the adhesive monomer for dental material in the present invention has a function of improving the adhesive strength with the tooth during the dental treatment, and a property of increasing the mechanical strength of the cured material of the blended dental material, It is particularly suitable for dental adhesives and dental primer applications.
- the adhesive monomer for dental material in the present invention is in the molecule as described above. It contains both phosphate groups and (meth) acryloyl groups, and the tooth surface etching ability derived from phosphoric acid, which is an acidic group, the interaction through the phosphate group to the tooth surface, and (meta ) It is inferred that it has the three functions of binding to the resin matrix via the acryloyl group. Moreover, the adhesive monomer for dental materials in the present invention has a carbamate structure in the molecule.
- the carbamate structure is known to show the effect of giving high mechanical properties to the urethane polymer due to its aggregating action in the so-called urethane polymer, but also in the present invention, the adhesive monomer for dental materials in the present invention is in the molecule. There is a possibility that the carbamate structure contained in has a positive influence on the strength after hardening of the dental material in the present invention.
- the method of using the dental material of the present invention is not particularly limited as long as it is generally known as a method of using the dental material.
- the dental material of the present invention as a bonding material
- the dental material is dried as necessary, and a known light irradiation device is used as necessary. After photocuring, the composite resin for filling is filled.
- the dental material of the present invention when used as an adhesive resin cement, the tooth surface and the surface to which the prosthesis is bonded are subjected to primer treatment on the prosthesis as necessary, and then the dental material of the present invention is applied. Attach the prosthesis to a predetermined place in the oral cavity.
- the dental material of the present invention when used as a primer for dentin, the dental material is applied to the cavity in the oral cavity, and then dried as necessary, and a known light is used as necessary. After photocuring using an irradiation apparatus, the prosthesis to which adhesive cement has been applied is pressed against the cavity.
- the dental material of the present invention when used as an adhesive composite resin for filling, the dental material is directly filled into the cavity in the oral cavity and then photocured using a known light irradiation device. Can be achieved.
- the kit of the present invention includes the dental material.
- the kit of the present invention includes a kit in which each component of the dental material is filled as one agent, a polymerization form, a storage stability, and the like. Examples of the kit include an agent.
- the kit of the present invention may contain other dental materials to be used at the same time other than the dental material of the present invention. Such a kit is used for applications such as a bonding material, an adhesive cement, a primer, and an adhesive composite resin.
- Example 1 0.80 g (1.7 mmol) of Compound 2 obtained in Production Example 1 and 2.5 g (5.3 mmol) of UDMA (2,2,4-trimethylhexamethylenebis (2-carbamoyloxyethyl) dimethacrylate) , And TEGDMA (triethylene glycol dimethacrylate: NK Ester 3G manufactured by Shin-Nakamura Chemical Co., Ltd.) 0.74 g (2.6 mmol) was placed in a container and stirred at 50 ° C. until uniform to obtain a polymerizable monomer composition. Got.
- UDMA 2,2,4-trimethylhexamethylenebis (2-carbamoyloxyethyl) dimethacrylate
- TEGDMA triethylene glycol dimethacrylate: NK Ester 3G manufactured by Shin-Nakamura Chemical Co., Ltd.
- Example 1 is an example of a composition suitable for evaluating the performance as a resin, for example.
- This surface was irradiated with light for 20 seconds using a visible light irradiation device (Translux 2 Wave, manufactured by Heraeus Kultzer). Further, a plastic mold (ULTRADENT) with a diameter of 2.38 mm is set on this, filled with a dental composite resin (Venus Diamond, made by Heraeus Kultzer), and irradiated with light for 20 seconds using a visible light irradiation device. And cured. Thereafter, the mold was removed to prepare an adhesion sample. After storing the sample in warm water at 37 ° C.
- a visible light irradiation device Translux 2 Wave, manufactured by Heraeus Kultzer
- Examples 2 to 8 The same operation as in Example 1 except that the monophosphate ester-containing methacrylate obtained in the above Production Example, Compound 4, 6, 8, 14, 18, 20, or 26 was used instead of Compound 2.
- the polymerizable monomer composition and the composition used as a dental material were prepared. Subsequently, the same test as in Example 1 was performed, and the results of bending strength and shear test were obtained. The results are shown in Table 2.
- the adhesive monomer for dental materials of the present invention has not only high adhesive strength to the tooth of the blended composition, but also the blending thereof compared with the conventional adhesive monomer for dental materials. It turns out that it is excellent in the intensity
- Example 9 1.2 g (60 parts by weight) of the compound 2 obtained in Production Example 1 and 0.6 g (30 parts by weight) of UDMA (2,2,4-trimethylhexamethylenebis (2-carbamoyloxyethyl) dimethacrylate) , And TEGDMA (triethylene glycol dimethacrylate: NK ester 3G manufactured by Shin-Nakamura Chemical Co., Ltd.) 0.2 g (10 parts by weight) in a container and stirred at 50 ° C. until uniform, polymerizable monomer composition Got.
- UDMA 2,2,4-trimethylhexamethylenebis (2-carbamoyloxyethyl) dimethacrylate
- TEGDMA triethylene glycol dimethacrylate: NK ester 3G manufactured by Shin-Nakamura Chemical Co., Ltd.
- TPO 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide: IRGACURE TPO, manufactured by BASF
- IRGACURE TPO IRGACURE TPO
- the composition of Example 9 is an example of a composition suitable for evaluating performance as a resin, for example. Except that bovine enamel and bovine dentin were used, the same test as in Example 1 was performed, and the results of bending strength and shear test were obtained. The results are shown in Table 3.
- Example 10 to 17 The same operation as in Example 9 was performed except that the phosphate group-containing methacrylate 4, 6, 8, 14, 16, 18, 20, 20 or 26 obtained in the above Production Example was used instead of Compound 2. And a composition for use as a dental material was prepared. Next, the same test as in Example 9 was performed, and the results of bending strength and shear test were obtained. The results are shown in Table 3.
- Example 2 A composition used as a dental material was prepared in the same manner as in Example 9 except that MDP (dihydrogen dihydrogen phosphate 10-methacryloyloxydecyl) was used in place of Compound 2. Next, the same test as in Example 9 was performed, and the result of the shear test was obtained. The results are shown in Table 3.
- Example 18 to 21 The same procedure as in Example 9 was performed except that the phosphate ester group-containing methacrylate 10, 12, 22 or 24 obtained in the above production example was used instead of the compound 2, and the composition used as a dental material Prepared. Next, the same test as in Example 9 was performed, and the result of the shear test was obtained. The results are shown in Table 4.
- the adhesive monomer for dental materials of the present invention has higher adhesiveness to the dentin of the blended composition than the conventional adhesive monomers for dental materials.
- Example 22 0.48 g (8.0 parts by weight) of Compound 2 obtained in Production Example 1 and 1.2 g (20 parts by weight) of UDMA (2,2,4-trimethylhexamethylenebis (2-carbamoyloxyethyl) dimethacrylate) Part), TEGDMA (triethyl glycol dimethacrylate: NK ester 3G manufactured by Shin-Nakamura Chemical Co., Ltd.) 0.6 g (10 parts by weight), and 4-META (4-methacrylooxyethyl trimellitic anhydride: Wako Pure Chemical Industries, Ltd.) Kogyo Co., Ltd.) 0.12 g (2.0 parts by weight), CQ (camphorquinone: Wako Pure Chemical Industries, Ltd.) 0.012 g (0.2 parts by weight), and 4- (dimethylamino) benzoic acid 0.024 g (0.4 parts by weight) of 2-butoxyethyl (manufactured by Tokyo Chemical Industry Co., Ltd.) was placed in
- Example 22 is an example of a composition suitable for evaluating performance as a resin, for example.
- Example 3 A composition used as a dental material was prepared in the same manner as in Example 22 except that MDP (dihydrogen dihydrogen phosphate 10-methacryloyloxydecyl) was used instead of Compound 2. Subsequently, the same test as in Example 22 was performed, and the results of the bending test and the shear test were obtained. The results are shown in Table 5.
- MDP dihydrogen dihydrogen phosphate 10-methacryloyloxydecyl
- Example 23 1.0 g (4.7 parts by weight) of Compound 2 obtained in Production Example 1, 6.0 g (28 parts by weight) of Bis-GMA (bisphenol A diglycidyl methacrylate: Shin-Nakamura Chemical Co., Ltd.), and HEMA (Mitsubishi Rayon Co., Ltd., Acryester HO (registered trademark)) 6.0 g (28 parts by weight) and TPO (2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide: IRGACURE TPO, manufactured by BASF) 0 0.020 g (0.94 parts by weight), CQ (camphorquinone: Wako Pure Chemical Industries, Ltd.) 0.40 g (1.9 parts by weight), ethyl 4- (dimethylamino) benzoate (Wako Pure Chemical Industries, Ltd.) ) 0.20 g (0.94 parts by weight), p-tolyldiethanolamine (manufactured by Tokyo Chemical Industry Co., Ltd.) 0.
- Example 22 is an example of a composition suitable for evaluating performance as a resin, for example.
- a test similar to that of Example 1 was performed except that bovine dentin was used and the solvent was removed by spraying weakly blown compressed air after the composition was applied to obtain a shear test result. The results are shown in Table 6.
- Example 4 A composition used as a dental material was prepared in the same manner as in Example 23 except that MDP (dihydrogen dihydrogen phosphate 10-methacryloyloxydecyl) was used in place of Compound 2. Next, the same operation as in Example 23 was performed, and the result of the shear test was obtained. The results are shown in Table 6.
- the adhesive monomer for dental material of the present invention has higher adhesive force to the tooth of the blended composition compared to the conventional adhesive monomer for dental material. It was confirmed that the cured product of the blended composition had sufficient mechanical strength.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Plastic & Reconstructive Surgery (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Dental Preparations (AREA)
Abstract
Description
[1]下記核部(X)と下記末端基(Y1)とが直接または下記連結基(Z)を介して結合した下記一般式(1)で示される化合物を含む歯科材料用接着性モノマー。
核部(X)は酸素原子または窒素原子を含有し、末端基(Y1)または連結基(Z)と結合する原子が酸素原子または窒素原子である炭素数1~200の3価以上の多価有機基であり、
末端基(Y1)は、下記一般式(2)で示されるリン含有基、下記一般式(3)で示されるリン含有基、下記一般式(4)で示される(メタ)アクリロイル基含有基(Y2)、(メタ)アクリロイル基、炭素数1~20の炭化水素基、または水素原子であり、複数ある末端基(Y1)は同一でも異なっていてもよく、ただし、一般式(1)で示される化合物中のすべての末端基(Y1)のうち、1以上は下記一般式(2)で示されるリン含有基または下記一般式(3)で示されるリン含有基であり、かつ1以上は(メタ)アクリロイル基含有基(Y2)であり、
連結基(Z)は下記一般式(5)で示される2価の基であり、上記一般式(1)で示される化合物中に連結基(Z)が複数含まれる場合には、連結基(Z)は同一でも異なっていてもよい。)
[3]上記末端基(Y1)が、上記一般式(2)で示されるリン含有基、上記一般式(3)で示されるリン含有基、または上記一般式(4)で示される(メタ)アクリロイル基含有基(Y2)である[1]または[2]に記載の歯科材料用接着性モノマー。
[4]上記連結基(Z)におけるn5a、n5b、n5c、およびn5dがそれぞれ0~20であり、n5a、n5b、n5c、およびn5dの合計が1~20である[1]~[3]のいずれかに記載の歯科材料用接着性モノマー。
[5]上記連結基(Z)が下記一般式(6)で示される2価の基である[1]~[4]のいずれかに記載の歯科材料用接着性モノマー。
[8]上記核部(X)が、下記一般式(8a)~(8j)で示される基からなる群より選択される少なくとも1つである[1]~[7]のいずれかに記載の歯科材料用接着性モノマー。
本発明の歯科材料用接着性モノマーは、下記核部(X)と下記末端基(Y1)とが直接または下記連結基(Z)を介して結合した下記一般式(1)で示される化合物である。
上記核部(X)は、酸素原子または窒素原子を含有し、末端基(Y1)または連結基(Z)と結合する原子が酸素原子または窒素原子である3価以上の多価有機基である。上記末端基(Y1)または連結基(Z)と結合する酸素原子または窒素原子は、上記末端基(Y1)または連結基(Z)以外とは、メチレン基または2価の芳香族性炭素基と結合している。なおこのメチレン基または2価の芳香族炭素基に含まれる任意の水素原子は、炭素数1~12の一価の炭化水素基と置き換えられていてもよい。核部(X)の炭素数は通常1~200の範囲であるが、好ましくは1~100であり、より好ましくは1~30、さらに好ましくは2~20である。
末端基(Y1)は、下記一般式(2)で示されるリン含有基、下記一般式(3)で示されるリン含有基、下記一般式(4)で示される(メタ)アクリロイル基含有基(Y2)、(メタ)アクリロイル基、炭素数1~20の炭化水素基または水素原子であり、複数ある末端基(Y1)は同一でも異なっていてもよく、ただし、一般式(1)で示される化合物中のすべての末端基(Y1)のうち、1以上は下記一般式(2)で示されるリン含有基または下記一般式(3)で示されるリン含有基であり、かつ1以上は(メタ)アクリロイル基含有基(Y2)である。
連結基(Z)は下記一般式(5)で示される2価の基であり、上記一般式(1)で示される化合物中に連結基(Z)が複数含まれる場合には、連結基(Z)は同一でも異なっていてもよい。
上記の繰り返し単位は、1種類で構成されていてもよいし、2種類以上で構成されていてもよい。2種以上の繰り返し単位を含む場合、これら繰り返し単位が含まれる形態については特に制限はなく、例えばランダムに各繰り返し単位が含まれていてもよいし、ある繰り返し単位がある一定の個数固まった形態、すなわちブロック的に各繰り返し単位が含まれていてもよい。また、これらの繰り返し単位の順番については、何ら限定されない。
本発明の歯科材料用接着性モノマーは、公知の方法により製造できる。
例えば、対応する水酸基含有化合物またはアミノ基含有化合物、好ましくは対応する水酸基含有化合物と、公知のリン酸化剤(例えば五酸化リン、五塩化リン、三塩化リン、オキシ塩化リン、または五硫化リン等)とを、公知の方法で反応させることにより、該化合物に含まれる水酸基またはアミノ基、好ましくは水酸基がリン酸エステル化またはリン酸アミド化されることにより製造される。
末端基(Y3)は、上記一般式(4)で示される(メタ)アクリロイル基含有基(Y2)、(メタ)アクリロイル基、炭素数1~20の炭化水素基、または水素原子であり、上記一般式(4)で示される(メタ)アクリロイル基含有基(Y2)、(メタ)アクリロイル基、または水素原子であることが好ましく、上記一般式(4)で示される(メタ)アクリロイル基含有基(Y2)、または水素原子がより好ましい。複数ある末端基(Y3)は同一でも異なっていてもよい。ただし、一般式(11)で示される化合物中のすべての末端基(Y3)のうち、1以上は(メタ)アクリロイル基含有基(Y2)であり、かつ1以上は水素原子であり、好ましくは、2以上は(メタ)アクリロイル基含有基(Y2)であり、かつ1以上は水素原子である。
一般式(11)の化合物としては、例えば以下の一般式(11a)~(11v)で示される(メタ)アクリロイル基含有基(Y2)含有アルコールまたは(メタ)アクリロイル基含有基(Y2)含有ポリオールが挙げられる。
本発明の歯科材料用モノマー組成物は、後述する歯科材料に配合されうる本発明の歯科材料用接着性モノマー以外の重合可能なモノマー(例えば、本発明の歯科材料用接着性モノマー以外の(メタ)アクリレート基含有モノマー)を含有してもよく、含有しなくてもよい。
本発明の歯科材料用モノマー組成物は、復帰突然変異試験において陰性を示すものであることが望ましい。復帰突然変異試験(Ames試験)とは、歯科材料用モノマー組成物の変異原性を、微生物を使って調べる試験を意味する。本発明における復帰突然変異試験は、以下の方法で行われる。
まず、滅菌した試験管に、ジメチルスルホキシド(DMSO)を媒体とする被験組成物液0.1mLと、代謝活性化しない場合は0.1Mリン酸緩衝液(pH7.4)を、代謝活性化する場合は後述するS9mixをそれぞれ0.5mL加えた後、後述する菌懸濁液0.1mLを加え混合する。37℃、約100rpmで20分間プレインキュベーションした後、後述するトップアガー2mLを加えて混和し、後述する最少グルコース寒天平板培地上(5用量以上)に重層する。重層固化を確認した後、最少グルコース寒天平板培地の上下を反転し、37°Cで48時間培養する。培養後のプレートについて、陰性・陽性の判定を行う。なお、陰性対照物質について試験を行う場合は、陰性対照物質としてDMSOを用い、上記の工程における被験組成物液に代えて媒体0.1mLを加える。
陰性・陽性の判断基準に関して、被験組成物が、全ての菌株・全ての用量において、また、代謝活性化しない場合および代謝活性化する場合の両方において、陰性対象物質のみの場合と比較して、平均コロニー数が2倍以内である場合に、その歯科材料用モノマー組成物は陰性と判断する。
用量当たりの最少グルコース寒天平板培地は、陰性対照物質については2枚以上、被験組成物についても2枚以上とする。
本発明の歯科材料用モノマー組成物は、後述するBalb/3T3細胞を用いるNRU法による細胞毒性試験において、相対細胞生存率が一定の範囲内であってもよい。該細胞毒性試験は、以下の方法で行う。
陰性対照液は、D05培養液にDMSOを0.5v/v%になるよう添加して調製する。
D10培養液とは、仔牛血清10vol%、ペニシリン-ストレプトマイシン-アムホテリシンB懸濁液1vol%、100mmol/Lピルビン酸ナトリウム溶液1vol%を含むD-MEMのことを指す。
上述のBalb/3T3細胞の前培養は、まず対数増殖期にある細胞をトリプシン-EDTAを用いて単離した後、D05培養液を用いて細胞濃度1x105cells/mLの細胞懸濁液を調製してから、細胞懸濁液0.1mLを96ウェルプレートに分注播種し(1x104cells/well)、CO2インキュベーター内で25時間静置して行う。
NR(ニュートラルレッド)ストック液とは、ニュートラルレッド(NR)(和光純薬工業株式会社製)の0.4%(w/v)水溶液を指す。
NR再溶解液とは、酢酸、エタノール、水を1:50:49で混合したものを指す。使用前1時間以内に調製する。
本発明の歯科材料用モノマー組成物は、Balb/3T3細胞を用いるWST法による細胞試験において、相対細胞増殖率が一定の範囲内であってもよい。該細胞試験は、以下の方法で行う。
陰性対照液は、DMSOをDMEM培養液により0.5vol%になるよう添加して調製する。
DMEM培養液とは、仔牛血清10vol%、ペニシリン-ストレプトマイシン-アムホテリシンB懸濁液(x100)1vol%を含むDulbecco’s Modified Eagle’s Medium(D-MEM)を指す。
上述のBalb/3T3細胞の前培養は、まず対数増殖期にあるBalb/3T3 clone A31細胞を0.25%トリプシン-1mM EDTAを用いて単離した後、DMEM培養液を用いて細胞濃度20000cells/mLの細胞懸濁液を調製してから、細胞懸濁液0.1mLを96ウェルプレートに分注播種し(2000cells/ウェル)、CO2インキュベーター内で24時間静置して行う。
本発明の歯科材料用接着性モノマーは、本発明の歯科材料用接着性モノマーを含む歯科材料の硬化物に十分な機械強度を与えつつ、歯科治療の際に歯質との接着強度を向上させることができるため、歯科材料の原料として好適である。本発明の歯科材料用接着性モノマーに対して、本発明の歯科材料用接着性モノマー以外の成分(例えば、本発明の歯科材料用接着性モノマー以外の重合可能なモノマー(本発明の歯科材料用接着性モノマー以外の(メタ)アクリレート基含有モノマー、エポキシ基を含有するモノマー等)を配合することによって、本発明の歯科材料用接着性モノマーを含有する歯科材料を製造することができる。
本発明の歯科材料用接着性モノマー以外の成分の一例としては、本発明の歯科材料用接着性モノマー以外の(メタ)アクリレート基含有モノマーを挙げることができる。
重合性基を1つだけ有する上記の歯科材料用接着性モノマー以外の(メタ)アクリレート基含有モノマーとしては、例えば、下記一般式(21)で示されるモノマーが挙げられる。
上記二価の有機基としては、例えば、アルキレン基等の炭素数1~20の非環状炭化水素基、シクロアルキレン基、アリーレン基等の炭素数1~20の環状炭化水素基などの炭化水素基;オキシアルキレン基等の上記炭化水素基の少なくとも一部の炭素-炭素結合の間に、酸素が挿入された基(ただし酸素が連続して挿入されることはない。)などの炭素数1~20の酸素含有炭化水素基等が挙げられる。上記炭素数1~20の環状炭化水素基は、非環状炭化水素部分を有していてもよい。また、これら基中に含まれる非環状炭化水素部分は直鎖状または分岐状のいずれでもよい。
アクリロイル基とピロリン酸残基とを有するモノマーとしては、例えば、ピロリン酸ジ(2-アクリロイルオキシエチル)およびこれらの酸塩化物などが挙げられる。
本発明の歯科材料に含まれる本発明の歯科材料用接着性モノマー以外の成分の別の一例としては、重合開始剤を挙げることができる。
常温重合を行う場合には、たとえば、酸化剤および還元剤を組み合わせたレドックス系の重合開始剤が好適である。レドックス系の重合開始剤を使用する場合、酸化剤と還元剤が別々に包装された形態をとり、使用する直前に両者を混合する必要がある。
過酸化物としては特に限定されないが、例えば、過酸化ベンゾイル、t-ブチルヒドロペルオキシド、クメンヒドロペルオキシドなどが挙げられる。アゾ系化合物としては特に限定されないが、例えば、アゾビスイソブチロニトリルなどが挙げられる。
光重合開始剤としては、特に限定されないが、例えば、α-ジケトン/還元剤、ケタール/還元剤、チオキサントン/還元剤などが挙げられる。α-ジケトンとしては、例えば、カンファーキノン、ベンジルおよび2,3-ペンタンジオンなどが挙げられる。ケタールとしては、例えば、ベンジルジメチルケタールおよびベンジルジエチルケタールなどが挙げられる。チオキサントンとしては、例えば、2-クロロチオキサントンおよび2,4-ジエチルチオキサントンなどが挙げられる。還元剤としては、例えば、ミヒラ-ケトン等、2-(ジメチルアミノ)エチルメタクリレート、N,N-ビス〔(メタ)アクリロイルオキシエチル〕-N-メチルアミン、N,N-ジメチルアミノ安息香酸エチル、4-ジメチルアミノ安息香酸ブチル、4-ジメチルアミノ安息香酸ブトキシエチル、N-メチルジエタノールアミン、4-ジメチルアミノベンゾフェノン、N,N-ビス(2-ヒドロキシエチル)-p-トルイジンおよびジメチルアミノフェナントール等の第三級アミン;シトロネラール、ラウリルアルデヒド、フタルジアルデヒド、ジメチルアミノベンズアルデヒドおよびテレフタルアルデヒド等のアルデヒド類;2-メルカプトベンゾオキサゾール、デカンチオール、3-メルカプトプロピルトリメトキシシラン、4-メルカプトアセトフェノン、チオサリチル酸およびチオ安息香酸等のチオール基を有する化合物;等を挙げることができる。これらのレドックス系に有機過酸化物を添加したα-ジケトン/有機過酸化物/還元剤の系も好適に用いられる。
本発明の歯科材料に含まれる本発明の歯科材料用接着性モノマー以外の成分の別の一例としては、フィラーを挙げることができる。
有機フィラーとしては、例えば、ポリメタクリル酸メチル、ポリメタクリル酸エチル、メタクリル酸メチル-メタクリル酸エチル共重合体、架橋型ポリメタクリル酸メチル、架橋型ポリメタクリル酸エチル、エチレン-酢酸ビニル共重合体およびスチレン-ブタジエン共重合体などの微粉末が挙げられる。
粒径が0.1μm以下のミクロフィラーが配合された歯科材料は、歯科用コンポジットレジンに好適な態様の一つである。かかる粒径の小さなフィラーの材質としては、シリカ(例えば、商品名アエロジル)、アルミナ、ジルコニア、チタニアなどが好ましい。このような粒径の小さい無機フィラーの配合は、コンポジットレジンの硬化物の研磨滑沢性を得る上で有利である。
本発明の歯科材料は、上述の本発明の歯科材料用接着性モノマー、本発明の歯科材料用接着性モノマー以外の重合可能なモノマー(例えば、本発明の歯科材料用接着性モノマー以外の(メタ)アクリレート基含有モノマー、エポキシ基を有するモノマー)、重合開始剤、およびフィラー以外の成分を、目的に応じて適宜含んでもよい。例えば、保存安定性を向上させるために既に上述した重合禁止剤を含んでもよい。また、色調を調整するために、公知の顔料、染料等の色素を含みうる。さらに、硬化物の強度を向上させるために、公知のファイバー等の補強材を含んでもよい。その他、必要に応じて、アセトン、エタノール、水等の溶媒も含んでもよい。
本発明の歯科材料用接着性モノマーの歯科材料への配合量は特に制限されないが、例えば0.1~99%の範囲である。好ましい配合量は、その歯科材料用の用途によって異なる場合もあるが、例えば重合性モノマー成分(上記の歯科材料用水酸基含有モノマーと上記の歯科材料用水酸基含有モノマー以外の重合可能なモノマー(例えば、本発明の歯科材料用接着性モノマー以外の(メタ)アクリレート基含有モノマー、エポキシ基を有するモノマー)中に1~60重量%配合される。特に、歯科材料用途が、歯科用接着材(ボンディング材、接着レジンセメント、充填用接着コンポジットレジン)、歯科用プライマー、歯牙裂溝封鎖材である場合、歯科材料用接着性モノマーの配合量は、重合性モノマー成分中に1~60重量%であることが好ましい。
本発明の歯科材料は、復帰突然変異試験において陰性を示すものであることが望ましい。復帰突然変異試験(Ames試験)の試験方法は、上述の復帰突然変異試験の方法において、本発明の歯科材料用モノマー組成物を本発明の歯科材料に置き換えて、同様の手順で行う。
本発明の歯科材料は、Balb/3T3細胞を用いるNRU法による細胞試験において、相対細胞生存率が一定の範囲内であってもよい。該細胞試験は、上述のNRU法による細胞試験において、本発明の歯科材料用モノマー組成物を本発明の歯科材料に置き換えて、同様の手順で行う。また、被験材料に含まれる被験物質(歯科材料に含まれる歯科材料用接着性モノマー)の試験液中の濃度、歯科材料の相対細胞増殖率(%)は、上述の本発明の歯科材料用モノマー組成物の場合におけるものと同様であってよい。
本発明の歯科材料は、Balb/3T3細胞を用いるWST法による細胞試験において、相対細胞増殖率が一定の範囲内であってもよい。該細胞試験は、上述のWST法による細胞試験において、本発明の歯科材料用モノマー組成物を本発明の歯科材料に置き換えて、同様の手順で行う。また、被験材料に含まれる被験物質(歯科材料に含まれる歯科材料用接着性モノマー()の試験液中の濃度、歯科材料の相対細胞増殖率(%)は、上述の本発明の歯科材料用モノマー組成物の場合におけるものと同様であってよい。
上述の本発明の歯科材料用接着性モノマー、本発明の歯科材料用接着性モノマー以外の重合可能なモノマー(例えば、本発明の歯科材料用接着性モノマー以外の(メタ)アクリレート基含有モノマー、エポキシ基を有するモノマー)、重合開始剤、フィラー、その他の成分等を混和し、本発明の歯科材料を製造する方法については、公知の方法であれば特に制限を受けない。
本発明の歯科材料は、前述の重合開始剤の重合方式にあわせ適切な条件で硬化することができる。例えば、可視光照射による光重合開始剤を含有している本発明の歯科材料の場合は、該歯科材料を所定の形状に加工したのち、公知の光照射装置を用いて所定の時間可視光を照射することにより、所望の硬化物を得ることができる。照射強度、照射強度等の条件は、歯科材料の硬化性に合わせて適切に変更することができる。また、可視光をはじめとした、光照射により硬化した硬化物を、さらに適切な条件で熱処理をすることにより、硬化物の機械的物性を向上させることもできる。また、別の例として、加熱による重合開始剤を含有している本発明の歯科材料の場合は、該歯科材料を所定の形状に加工したのち、適切な温度及び時間加熱することにより、所望の硬化物を得ることができる。
以上のようにして得られる上述の本発明の歯科材料の硬化物が、歯科治療用途に用いられることもある。
本発明における歯科材料は、歯科治療用途に好適に用いることができ、例えば、充填用コンポジットレジン、歯冠用硬質レジン、義歯床用レジン、義歯床用裏装材、印象材、歯科用接着材(歯列矯正用接着材、ボンディング材、接着レジンセメント、充填用接着コンポジットレジン、およびレジン添加型グラスアイオノマーセメント)、歯科用プライマー、歯牙裂溝封鎖材、CAD/CAM用レジンブロック、テンポラリークラウン、および人工歯材料等を挙げることができる。本発明における歯科材料用接着性モノマーは、歯科治療の際に歯質との接着強度を向上させる機能、および配合した歯科材料の硬化物の機械的強度が高くなる性質を有しているため、特に歯科用接着材、歯科用プライマー用途に好適である。
本発明の歯科材料の使用方法は、歯科材料の使用法として一般に知られているものであれば、特に制限されない。例えば、本発明の歯科材料をボンディング材として使用する場合は、口腔内の窩洞に該歯科材料を塗付したのち、必要に応じて乾燥し、また必要に応じて公知の光照射装置を用いて光硬化させたのち、充填用コンポジットレジンを充填する。
本発明のキットは上記歯科材料を含む。本発明のキットは、上記歯科材料の各成分を1剤として充填したキット、重合形式、および保存安定性等を勘案して、上記歯科材料の各成分を2剤以上に分けて充填した複数の剤からなるキットなどが挙げられる。なお、本発明のキットには、本発明の歯科材料以外の、同時に使用する他の歯科材料が含まれていてもよい。かかるキットは、ボンディング材、接着セメント、プライマー、接着コンポジットレジンなどの用途に用いられる。
[製造例1]
撹拌羽根、温度計および還流管を備えた500ミリリットル四つ口フラスコ内に、グリセリン(シグマアルドリッチ社製)100g(1.09mol、OH基モル数3.27mol)とジブチル錫ジラウレート(和光純薬工業株式会社製)0.43g(反応全基質重量に対して1000ppm)および2,6-t-ブチルー4-メチルフェノール(和光純薬工業株式会社製)を0.22g(反応全基質重量に対して500ppm)を添加し、55℃に昇温した。続いて、2-メタクリロイルオキシエチルイソシアネート(昭和電工株式会社製、カレンズMOI(登録商標))337g(2.17mol、用いたグリセリンのOHモル数に対して2/3当量)を30分かけて滴下した。80~85℃となるように温度を保ち、4時間反応を行った。赤外吸収スペクトルIR(パーキンエルマー社製,Spectrum Two)を測定したところ、2267cm-1のイソシアネート由来の振動が消失したことを確認した。生成物の一部を採取しJIS K 0070に従い水酸基価を測定したところ、138mgKOH/gであった。反応生成物の液体クロマトグラフィー質量分析(LC-MS分析)(日本Waters株式会社製、ACQUITY UPLC BEH C181.7μm(2.1mmx10mm)/ACQUITY UPLC H-Class-SQ Detector 2)を行ったところ、化合物1の分子量402と合致する質量[M-H]+:403が検出された。反応器から排出することにより、下記化合物1を含む生成物417gが得られた。
製造例1に記載のグリセリンに代わり、ジグリセリン(ナカライテスク株式会社製)を用いて製造例1と同様の合成操作を行うことで、下記化合物3の構造式を有する化合物3、次いで下記化合物4の構造式を有するリン酸エステル含有化合物4を含む生成物を得た。
製造例1に記載の2―メタクリロイルオキシエチルイソシアネート カレンズMOI(登録商標)に代わり、分子内にオキシエチレンユニットを導入したカレンズMOI-EG(登録商標)(昭和電工株式会社製)を用いて製造例1と同様の合成操作を行うことで、下記化合物5の構造式を有する化合物5、次いで下記化合物6の構造式を有するリン酸エステル含有化合物6を含む生成物を得た。
撹拌羽根、温度計および還流管を備えた300ミリリットル四つ口フラスコ内に、下記表1中の構造式を有するポリオール1(三井化学株式会社製アクトコール(登録商標)、平均分子量182、水酸基価926mgKOH/g)99.0g(OH基:1.63mol)とジブチル錫ジラウレート0.27g(反応全基質重量に対して1000ppm)および2,6-t-ブチルー4-メチルフェノール0.14g(反応全基質重量に対して500ppm)を添加し、55℃に昇温した。続いて、カレンズMOI171g(1.10mol、用いたポリオール1のOHモル数に対して2/3当量)を20分かけて滴下した。80-85℃となるように反応温度を保ち、8時間反応を行った。IRを測定したところ、2267cm-1のイソシアネート由来の振動が消失していることを確認した。生成物の一部を採取しJIS K 0070に従い水酸基価を測定したところ、119mgKOH/gであった。反応生成物のLC-MS分析を行ったところ、主生成物としてオキシエチレンが一つ誘導されたa+b+c=1の化合物1の分子量488と合致する質量[M-H]+:489および[M-Na]+:511が検出された。反応器から排出することにより、下記化合物7の構造式を有する水酸基含有モノマーを含む生成物 260gが得られた。
製造例4に記載のポリオールに代わり、下記表1に示すポリオールを用いて製造例4と同様の合成操作を行うことで、下記化合物9~18、25、26の構造式を有する化合物を含む生成物を得た。
製造例3に記載のポリオールに代わり、下記表1に示すポリオールを用いて製造例4と同様の合成操作を行うことで、下記化合物19~22の構造式を有する化合物を含む生成物を得た。
製造例4に記載のカレンズMOIの代わりに、カレンズMOI-EGを下記表1に示すポリオールのOHモル数に対して1/2当量を用いて製造例4と同様の合成操作を行うことで、下記化合物23、24の構造式を有する化合物を含む生成物を得た。
製造例1で得られた化合物2を0.80g(1.7mmol)と、UDMA(2,2,4-トリメチルヘキサメチレンビス(2-カルバモイルオキシエチル)ジメタクリレート)2.5g(5.3mmol)、およびTEGDMA (トリエチレングリコールジメタクリレート:新中村化学工業株式会社製NKエステル3G) 0.74g(2.6mmol)とを容器に入れ、均一になるまで50 ℃で撹拌して重合性モノマー組成物を得た。次いで、上記重合性モノマー組成物100重量部に対して、TPO(2,4,6-トリメチルベンゾイル-ジフェニル-フォスフィンオキサイド:IRGACURE TPO、BASF社製)0.5重量部を添加、混合し、均一なペーストの歯科材料として用いる組成物を得た。なお、実施例1の組成物は、例えば、レジンとしての性能を評価するのに適した組成の一例である。
上記で調製した組成物を2×2×25mmのSUS製金型に充填し、カバーフィルムで上から挟んだ後、歯科用可視光線照射装置(αライトV、株式会社モリタ東京製作所製)で片面につき3分間、両面から合計6分間照射して、組成物を硬化させた。硬化物を37℃の脱イオン水中で24時間保存した後、汎用試験機(精密万能材料試験機210X、株式会社INTESCO製)を用いて支点間距離20mm、クロスヘッド速度1.0mm/分で3点曲げ試験を実施した。該歯科材料として用いる組成物の硬化物の曲げ試験の結果を表2に示す。
抜去した後冷凍保存した牛下顎前歯を注水下解凍し、歯根切断、抜髄処理した。これを直径25mm、深さ25mmのプラスチック製円筒容器に設置し、アクリル樹脂中に包埋した。この表面を#120、#400のエメリーペーパーを用いて湿式研磨し、唇面と平行になるようにエナメル質を削り出した。
次に、この平面に圧縮空気を約1秒間吹き付けて乾燥した後、エナメル質の平面に作成した組成物を塗布し、弱ブローの圧縮空気を吹き付けた。この表面に可視光照射装置(Translux 2Wave、ヘレウスクルツァー社製)を用いて20秒光照射した。更にこの上に直径2.38mmのプラスチック製モールド(ULTRADENT社製)を設置し、歯科用コンポジットレジン(Venus Diamond、ヘレウスクルツァー社製)を充填し、可視光照射装置を用いて20秒光照射し、硬化させた。その後、モールドを除去し、接着試料を作成した。試料を37℃温水中24時間保管した後、汎用試験機(精密万能材料試験機210X、株式会社INTESCO製)を用いて、牛歯のエナメル質に平行、かつ表面に接して1.0mm/分のクロスヘッド速度で剪断負荷を掛け、牛歯表面に柱状に形成させた組成物が表面から分離する時の剪断負荷から、剪断接着強度を求めた。
該歯科材料用組成物の剪断試験の結果を表2に示す。
化合物2の代わりに、上記製造例で得られたモノリン酸エステル基含有メタクリルレート、化合物4、6、8、14、18、20、または26を用いたこと以外は、実施例1と同様の操作を行い、重合性モノマー組成物の調製、および歯科材料として用いる組成物の調製を行った。ついで実施例1と同様の試験を行い、曲げ強度および剪断試験の結果を得た。
結果を表2に示す。
化合物2の代わりに、MDP(リン酸二水素10-メタクリロイルオキシデシル)を用いたこと以外は、実施例1と同様の操作を行い、重合性モノマー組成物の調製、および歯科材料として用いる組成物の調製を行った。ついで実施例1と同様の試験を行い、曲げ強度および剪断試験の結果を得た。結果を表2に示す。
製造例1で得られた化合物2を1.2g(60重量部)と、UDMA(2,2,4-トリメチルヘキサメチレンビス(2-カルバモイルオキシエチル)ジメタクリレート)0.6g(30重量部)、およびTEGDMA(トリエチレングリコールジメタクリレート:新中村化学工業株式会社製NKエステル3G) 0.2g(10重量部)とを容器に入れ、均一になるまで50℃で撹拌して重合性モノマー組成物を得た。次いで、上記重合性モノマー組成物100重量部に対して、TPO(2,4,6-トリメチルベンゾイル-ジフェニル-フォスフィンオキサイド:IRGACURE TPO、BASF社製)0.5重量部を添加、混合し、均一なペーストの歯科材料として用いる組成物を得た。実施例9の組成物は、例えば、レジンとしての性能を評価するのに適した組成の一例である。牛歯エナメル質及び牛歯象牙質を使用したこと以外は、実施例1と同様の試験を行い、曲げ強度および剪断試験の結果を得た。結果を表3に示す。
化合物2の代わりに、上記製造例で得られたリン酸エステル基含有メタクリルレート4、6、8、14、16、18、20または26を用いたこと以外は、実施例9と同様の操作を行い、歯科材料として用いる組成物の調製を行った。次いで実施例9と同様の試験を行い、曲げ強度および剪断試験の結果を得た。結果を表3に示す。
化合物2の代わりに、MDP(リン酸二水素10-メタクリロイルオキシデシル)を用いたこと以外は、実施例9と同様の操作を行い、歯科材料として用いる組成物の調製を行った。次いで実施例9と同様の試験を行い、剪断試験の結果を得た。結果を表3に示す。
化合物2の代わりに、上記製造例で得られたリン酸エステル基含有メタクリレート10、12、22または24を用いたこと以外は、実施例9と同様の操作を行い、歯科材料として用いる組成物の調製を行った。次いで実施例9と同様の試験を行い、剪断試験の結果を得た。結果を表4に示す。
製造例1で得られた化合物2を0.48g(8.0重量部)とUDMA(2,2,4-トリメチルヘキサメチレンビス(2-カルバモイルオキシエチル)ジメタクリレート)を1.2g(20重量部)、TEGDMA(トリエチルグリコールジメタクリレート:新中村化学工業株式会社製NKエステル3G)0.6g(10重量部)、および4-META(4-メタクリロオキシエチルトリメリット酸無水物:和光純薬工業株式会社製)0.12g(2.0重量部)と、CQ(カンファーキノン:和光純薬工業株式会社製)0.012g(0.2重量部)、および4-(ジメチルアミノ)安息香酸2-ブトキシエチル(東京化成工業株式会社製)0.024g(0.4重量部)とを容器に入れ、均一になるまで50℃で撹拌して混合物を得た。この混合物に、バリウムアウミニウムボロシリケートガラスフィラー(GM27884、粒径1.5μm、1.6%シラン処理品、NEC SCHOTTコンポーネンツ株式会社製)3.6g(59重量部)を添加、混合し、均一なペーストの歯科材料として用いる組成物を得た。実施例22の組成物は、例えば、レジンとしての性能を評価するのに適した組成の一例である。牛歯象牙質を使用し、圧縮空気を吹き付けた象牙質の平面にプラスチック製モールドを設置し、組成物を2回に分けて充填し、歯科用コンポジットレジン(Venus Diamond)を使用しなかったこと以外は、実施例1と同様の試験を行い、曲げ試験及び剪断試験の結果を得た。結果を表4に示す。
化合物2の代わりに、MDP(リン酸二水素10-メタクリロイルオキシデシル)を用いたこと以外は、実施例22と同様の操作を行い、歯科材料として用いる組成物の調製を行った。次いで実施例22と同様の試験を行い、曲げ試験および剪断試験の結果を得た。結果を表5に示す。
製造例1で得られた化合物2を1.0g(4.7重量部)とBis-GMA(ビスフェノールAジグリシジルメタクリレート:新中村化学工業株式会社製)6.0g(28重量部)、およびHEMA(三菱レイヨン株式会社製、アクリエステルHO(登録商標))6.0g(28重量部)と、TPO(2,4,6-トリメチルベンゾイル-ジフェニル-フォスフィンオキサイド:IRGACURE TPO、BASF社製)0.020g(0.94重量部)、CQ(カンファーキノン:和光純薬工業株式会社製)0.40g(1.9重量部)、エチル4-(ジメチルアミノ)ベンゾエート(和光純薬工業株式会社製)0.20g(0.94重量部)、p-トリルジエタノールアミン(東京化成工業株式会社製)0.20g(0.94重量部)、BHT(ジブチルヒドロキシトルエン:和光純薬工業株式会社製)3.0g(14重量部)、エタノール(超脱水:和光純薬工業株式会社製)3.0g(14重量部)、および蒸留水3.0g(14重量部)とを容器に入れ、均一になるまで50℃で撹拌して混合物を得た。この混合物に、バリウムアルミニウムボロシリケートガラスフィラー(GM27884、粒径1.5μm、1.6%シラン処理剤、NEC SCHOTTコンポーネンツ株式会社製)1.2g(5.7重量部)を添加、混合し、均一な液状の歯科材料として用いる組成物を得た。実施例22の組成物は、例えば、レジンとしての性能を評価するのに適した組成の一例である。牛歯象牙質を使用し、組成物を塗布後に弱ブローの圧縮空気を吹き付けて溶媒を除去したこと以外は、実施例1と同様の試験を行い、剪断試験の結果を得た。結果を表6に示す。
化合物2の代わりに、MDP(リン酸二水素10-メタクリロイルオキシデシル)を用いたこと以外は、実施例23と同様の操作を行い、歯科材料として用いる組成物の調製を行った。次いで実施例23と同様の操作を行い、剪断試験の結果を得た。結果を表6に示す。
Claims (14)
- 下記核部(X)と下記末端基(Y1)とが直接または下記連結基(Z)を介して結合した下記一般式(1)で示される化合物を含む歯科材料用接着性モノマー。
核部(X)は酸素原子または窒素原子を含有し、末端基(Y1)または連結基(Z)と結合する原子が酸素原子または窒素原子である炭素数1~200の3価以上の多価有機基であり、
末端基(Y1)は、下記一般式(2)で示されるリン含有基、下記一般式(3)で示されるリン含有基、下記一般式(4)で示される(メタ)アクリロイル基含有基(Y2)、(メタ)アクリロイル基、炭素数1~20の炭化水素基、または水素原子であり、複数ある末端基(Y1)は同一でも異なっていてもよく、ただし、一般式(1)で示される化合物中のすべての末端基(Y1)のうち、1以上は下記一般式(2)で示されるリン含有基または下記一般式(3)で示されるリン含有基であり、かつ1以上は(メタ)アクリロイル基含有基(Y2)であり、
連結基(Z)は下記一般式(5)で示される2価の基であり、上記一般式(1)で示される化合物中に連結基(Z)が複数含まれる場合には、連結基(Z)は同一でも異なっていてもよい。)
- 上記末端基(Y1)が、上記一般式(2)で示されるリン含有基、上記一般式(3)で示されるリン含有基、上記一般式(4)で示される(メタ)アクリロイル基含有基(Y2)または水素原子である請求項1に記載の歯科材料用接着性モノマー。
- 上記末端基(Y1)が、上記一般式(2)で示されるリン含有基、上記一般式(3)で示されるリン含有基、または上記一般式(4)で示される(メタ)アクリロイル基含有基(Y2)である請求項1または2に記載の歯科材料用接着性モノマー。
- 上記連結基(Z)におけるn5a、n5b、n5c、およびn5dがそれぞれ0~20であり、n5a、n5b、n5c、およびn5dの合計が1~20である請求項1~3のいずれか1項に記載の歯科材料用接着性モノマー。
- 上記核部(X)が、3~12価の有機基である請求項1~6のいずれか1項に記載の歯科材料用接着性モノマー。
- 請求項1~9のいずれか1項に記載の歯科材料用接着性モノマーを含有する歯科材料用モノマー組成物。
- 復帰突然変異試験において陰性を示す、請求項10に記載の歯科材料用モノマー組成物。
- 請求項1~9のいずれか1項に記載の歯科材料用接着性モノマーを含有する歯科材料。
- 復帰突然変異試験において陰性を示す、請求項12に記載の歯科材料。
- 請求項12または13に記載の歯科材料を含むキット。
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019510120A JP6734990B2 (ja) | 2017-03-31 | 2018-03-29 | 歯科材料用接着性モノマー |
US16/488,299 US11311462B2 (en) | 2017-03-31 | 2018-03-29 | Adhesive monomers for dental materials |
EP18777195.1A EP3603606A4 (en) | 2017-03-31 | 2018-03-29 | MONOMERIC ADHESIVE FOR DENTAL MATERIAL |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017072681 | 2017-03-31 | ||
JP2017-072681 | 2017-03-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018181707A1 true WO2018181707A1 (ja) | 2018-10-04 |
Family
ID=63677872
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2018/013232 WO2018181707A1 (ja) | 2017-03-31 | 2018-03-29 | 歯科材料用接着性モノマー |
Country Status (4)
Country | Link |
---|---|
US (1) | US11311462B2 (ja) |
EP (1) | EP3603606A4 (ja) |
JP (1) | JP6734990B2 (ja) |
WO (1) | WO2018181707A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020138071A1 (ja) * | 2018-12-28 | 2020-07-02 | 三井化学株式会社 | 歯科材料用モノマー組成物、歯科材料用組成物及び歯科材料 |
JP7218433B2 (ja) | 2019-12-27 | 2023-02-06 | 三井金属鉱業株式会社 | 硫化物固体電解質及びその製造方法 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11311462B2 (en) * | 2017-03-31 | 2022-04-26 | Mitsui Chemicals, Inc. | Adhesive monomers for dental materials |
WO2020046654A1 (en) * | 2018-08-30 | 2020-03-05 | 3M Innovative Properties Company | (meth)acrylate urethane (urea) phosphonates as adhesion promoters |
EP4312945A1 (de) * | 2021-04-02 | 2024-02-07 | Kulzer GmbH | Selbstadhäsives dentalmaterial |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5821607A (ja) | 1981-07-30 | 1983-02-08 | Kuraray Co Ltd | 歯科用接着剤 |
JPS6299388A (ja) * | 1985-10-22 | 1987-05-08 | ミネソタ マイニング アンド マニユフアクチユアリング コンパニ− | 磁気記録媒体 |
US20090043009A1 (en) | 2004-10-14 | 2009-02-12 | Junjie Sang | One-component self-etching adhesive |
JP2010235554A (ja) | 2009-03-31 | 2010-10-21 | Kuraray Medical Inc | リン酸エステル化合物及びそれを含む重合性組成物 |
WO2011041677A2 (en) * | 2009-10-01 | 2011-04-07 | Septodont, Confi-Dental Division | Novel multifunctional molecules for dental bonding applications having improved adhesion |
JP2017025058A (ja) * | 2015-07-22 | 2017-02-02 | イフォクレール ヴィヴァデント アクチェンゲゼルシャフトIvoclar Vivadent AG | 強酸性接着ポリマーを含む接着性歯科材料 |
EP3603606A1 (en) | 2017-03-31 | 2020-02-05 | Mitsui Chemicals, Inc. | Adhesive monomer for dental material |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4650847A (en) | 1981-07-29 | 1987-03-17 | Kuraray Co., Ltd. | Adhesive composition |
US4539382A (en) | 1981-07-29 | 1985-09-03 | Kuraray Co., Ltd. | Adhesive composition |
DE3269173D1 (en) | 1981-07-29 | 1986-03-27 | Kuraray Co | Adhesive composition |
JP4831993B2 (ja) | 2005-04-15 | 2011-12-07 | クラレメディカル株式会社 | 有機リン酸化合物 |
EP2755624B1 (de) * | 2011-12-06 | 2018-11-14 | Ivoclar Vivadent AG | Dentalmaterialien auf basis von stark aciden polymerisierbaren bisphosphonsäuren |
US9987199B2 (en) | 2012-07-10 | 2018-06-05 | Tokuyama Dental Corporation | Dental adhesive composition, dental adhesive primer, dental adhesive bonding material, dental adhesivecomposite resin, and dental adhesive resin cement |
JP5882874B2 (ja) * | 2012-11-02 | 2016-03-09 | クラレノリタケデンタル株式会社 | リン酸エステル化合物及びそれを含む重合性組成物 |
WO2018181711A1 (ja) | 2017-03-31 | 2018-10-04 | 三井化学株式会社 | リン含有化合物 |
-
2018
- 2018-03-29 US US16/488,299 patent/US11311462B2/en active Active
- 2018-03-29 WO PCT/JP2018/013232 patent/WO2018181707A1/ja active Application Filing
- 2018-03-29 EP EP18777195.1A patent/EP3603606A4/en active Pending
- 2018-03-29 JP JP2019510120A patent/JP6734990B2/ja active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5821607A (ja) | 1981-07-30 | 1983-02-08 | Kuraray Co Ltd | 歯科用接着剤 |
JPS6299388A (ja) * | 1985-10-22 | 1987-05-08 | ミネソタ マイニング アンド マニユフアクチユアリング コンパニ− | 磁気記録媒体 |
EP0225030A1 (en) | 1985-10-22 | 1987-06-10 | Minnesota Mining And Manufacturing Company | Radiation curable phosphorate ester compounds and magnetic recording medium incorporating cured phosphorate ester |
US20090043009A1 (en) | 2004-10-14 | 2009-02-12 | Junjie Sang | One-component self-etching adhesive |
JP2010235554A (ja) | 2009-03-31 | 2010-10-21 | Kuraray Medical Inc | リン酸エステル化合物及びそれを含む重合性組成物 |
WO2011041677A2 (en) * | 2009-10-01 | 2011-04-07 | Septodont, Confi-Dental Division | Novel multifunctional molecules for dental bonding applications having improved adhesion |
JP2017025058A (ja) * | 2015-07-22 | 2017-02-02 | イフォクレール ヴィヴァデント アクチェンゲゼルシャフトIvoclar Vivadent AG | 強酸性接着ポリマーを含む接着性歯科材料 |
EP3603606A1 (en) | 2017-03-31 | 2020-02-05 | Mitsui Chemicals, Inc. | Adhesive monomer for dental material |
Non-Patent Citations (2)
Title |
---|
NORBERT MOSZNER ET AL.: "Chemical aspects of self-etching enamel-dentin adhesives: A systematic review", DENTAL MATERIALS, vol. 21, 2005, pages 895 - 910 |
See also references of EP3603606A4 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020138071A1 (ja) * | 2018-12-28 | 2020-07-02 | 三井化学株式会社 | 歯科材料用モノマー組成物、歯科材料用組成物及び歯科材料 |
JPWO2020138071A1 (ja) * | 2018-12-28 | 2021-09-09 | 三井化学株式会社 | 歯科材料用モノマー組成物、歯科材料用組成物及び歯科材料 |
US20210338537A1 (en) * | 2018-12-28 | 2021-11-04 | Mitsui Chemicals, Inc. | Monomer composition for dental materials, composition for dental materials, and dental material |
EP3861975A4 (en) * | 2018-12-28 | 2022-06-29 | Mitsui Chemicals, Inc. | Monomer composition for dental materials, composition for dental materials, and dental material |
JP7121809B2 (ja) | 2018-12-28 | 2022-08-18 | 三井化学株式会社 | 歯科材料用モノマー組成物、歯科材料用組成物及び歯科材料 |
US11951193B2 (en) | 2018-12-28 | 2024-04-09 | Mitsui Chemicals, Inc. | Monomer composition for dental materials, composition for dental materials, and dental material |
JP7218433B2 (ja) | 2019-12-27 | 2023-02-06 | 三井金属鉱業株式会社 | 硫化物固体電解質及びその製造方法 |
Also Published As
Publication number | Publication date |
---|---|
US20190374440A1 (en) | 2019-12-12 |
EP3603606A4 (en) | 2020-10-28 |
US11311462B2 (en) | 2022-04-26 |
JPWO2018181707A1 (ja) | 2020-02-20 |
JP6734990B2 (ja) | 2020-08-05 |
EP3603606A1 (en) | 2020-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6734990B2 (ja) | 歯科材料用接着性モノマー | |
JP6514686B2 (ja) | 歯科材料用重合性モノマー | |
EP2918258B1 (en) | Polymerizable composition and dental material | |
JP2018177821A (ja) | 歯科材料用重合性モノマー、組成物、接着性歯科材料、及びキット | |
JP4673310B2 (ja) | 歯科用重合性組成物 | |
JP5931057B2 (ja) | 歯科材料、歯科材料組成物、歯科修復材料および硬化物 | |
JP5819415B2 (ja) | 新規な化合物、該化合物を含む組成物および硬化物 | |
US11786444B2 (en) | Dental polyfunctional monomers and dental hydroxyl group-containing monomers | |
JP6874123B2 (ja) | リン含有化合物 | |
JP6943531B2 (ja) | 新規耐酸性シランカップリング剤およびそれらを含有する医科歯科用硬化性組成物 | |
WO2022209973A1 (ja) | 歯科材料用組成物、歯科材料及び抗菌用組成物 | |
WO2023042715A1 (ja) | (メタ)アクリルアミド化合物、モノマー組成物、歯科材料用組成物及び歯科材料 | |
WO2022270601A1 (ja) | 歯科用接着キット |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18777195 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2019510120 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2018777195 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2018777195 Country of ref document: EP Effective date: 20191031 |